https://www.crosstreecapital.com/deals/lexitas-acquired-by-novaquest-to-support-continued-growth-and-capability-expansion2024-12-31https://www.crosstreecapital.com/deals/cmdx-financial-advisory2024-12-31https://www.crosstreecapital.com/what-we-do/investment-banking-serviceshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deep%206%20AITempus%20(315%20x%20315%20px).pngDeep6AITempus315x315pxDeep6AITempus315x315pxhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20Advisory.jpgMAAdvisoryMAAdvisoryhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sized.pngDealInsightCampaignTombstoneAlphaIRBSabaiGlobalSocialSizedDealInsightCampaignTombstoneAlphaIRBSabaiGlobalSocialSizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Calyx%20(Social%20Sized).V3-1.pngDealInsightCampaignTombstoneCalyxSocialSizedV31DealInsightCampaignTombstoneCalyxSocialSizedV31https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20mbr%20-%20New%20harbor.png2024mbrNewharbor2024mbrNewharborhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20sengenics%20(2).pngDealInsightTombstonesengenics2DealInsightTombstonesengenics2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/download-1-e1633377000585.pngdownload1e1633377000585download1e1633377000585https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20-%20Image.jpgMAImageMAImagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Soumitra-Chowdhury-website.pngSoumitraChowdhurywebsiteSoumitraChowdhurywebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Anju%20%2B%20Valsoft.pngDealInsightTombstoneAnjuValsoftDealInsightTombstoneAnjuValsofthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Logos/Ascent%20logo.pngAscentlogoAscentlogohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20-%20Higher%20Valuations.jpgMAHigherValuationsMAHigherValuationshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Tim-Billington-Pharmasol.pngTimBillingtonPharmasolTimBillingtonPharmasolhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2%20(1).pngDealInsightCampaignMyonexCreapharmSocialV21DealInsightCampaignMyonexCreapharmSocialV21https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Tombstone_ROI_01_28_2026-1.pngTombstoneROI012820261TombstoneROI012820261https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Biotechne.pngDealInsightTombstoneBiotechneDealInsightTombstoneBiotechnehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20BBIIBEX.pngDealInsightCampaignTombstoneBBIIBEXDealInsightCampaignTombstoneBBIIBEXhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20-%20Confident.jpgMAConfidentMAConfidenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20-%20Accelerate.jpgMAAccelerateMAAcceleratehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/John-Winebarger_photo-circle.pngJohnWinebargerphotocircleJohnWinebargerphotocirclehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/pharmasol_logo-rgb-768x204.pngpharmasollogorgb768x204pharmasollogorgb768x204https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2.pngDealInsightCampaignMyonexCreapharmSocialV2DealInsightCampaignMyonexCreapharmSocialV2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20-%20Process.jpgMAProcessMAProcesshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Yecuris%20(Social%20Sized)%20(NEW).pngDealInsightCampaignTombstoneYecurisSocialSizedNEWDealInsightCampaignTombstoneYecurisSocialSizedNEWhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20iPeople%20(3).pngDealInsightTombstoneiPeople3DealInsightTombstoneiPeople3https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCCRCNJ%20-%20Social.pngDealInsightCampaignLVCCRCNJSocialDealInsightCampaignLVCCRCNJSocialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20QDX%20-%20Hadley%20-%20LabGenomics.png2024QDXHadleyLabGenomics2024QDXHadleyLabGenomicshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Vax%20Trials%20-%20Emmes.png2024VaxTrialsEmmes2024VaxTrialsEmmeshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20ActiGraph%20(1).pngDealInsightTombstoneActiGraph1DealInsightTombstoneActiGraph1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Campaign%20Tombstone%20-%20PhysIQ%20(Social%20Sized)%20(1).pngDealCampaignTombstonePhysIQSocialSized1DealCampaignTombstonePhysIQSocialSized1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Continuum%20Clinical%20(Social%20Sized).pngDealInsightCampaignTombstoneContinuumClinicalSocialSizedDealInsightCampaignTombstoneContinuumClinicalSocialSizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCKerwin%20-%20Social.pngDealInsightCampaignLVCKerwinSocialDealInsightCampaignLVCKerwinSocial2024-02-15https://www.crosstreecapital.com/deals/mprove-health-acquired-by-bracket-october-24-20172024-12-31https://www.crosstreecapital.com/insights/events/wrib2025-03-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-october-20222024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-20232024-02-14https://www.crosstreecapital.com/insights/events/lp/world-drug-safety-congress-americas-20242024-09-23https://www.crosstreecapital.com/bluebooks/pharma-services-drug-development-bluebook-march-20252025-04-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-september-20202024-02-14https://www.crosstreecapital.com/dealshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20iPeople%20(3).pngDealInsightTombstoneiPeople3DealInsightTombstoneiPeople3https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Continuum%20Clinical%20(Social%20Sized).pngDealInsightCampaignTombstoneContinuumClinicalSocialSizedDealInsightCampaignTombstoneContinuumClinicalSocialSizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Versiti%20-%20Pearl%20Pathways.png2024VersitiPearlPathways2024VersitiPearlPathwayshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Tombstone_ROI_01_28_2026-1.pngTombstoneROI012820261TombstoneROI012820261https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Calyx%20(Social%20Sized).V3-1.pngDealInsightCampaignTombstoneCalyxSocialSizedV31DealInsightCampaignTombstoneCalyxSocialSizedV31https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Biotechne.pngDealInsightTombstoneBiotechneDealInsightTombstoneBiotechnehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20sengenics%20(2).pngDealInsightTombstonesengenics2DealInsightTombstonesengenics2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Campaign%20Tombstone%20-%20PhysIQ%20(Social%20Sized)%20(1).pngDealCampaignTombstonePhysIQSocialSized1DealCampaignTombstonePhysIQSocialSized1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20BBIIBEX.pngDealInsightCampaignTombstoneBBIIBEXDealInsightCampaignTombstoneBBIIBEXhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2%20(1).pngDealInsightCampaignMyonexCreapharmSocialV21DealInsightCampaignMyonexCreapharmSocialV21https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCCRCNJ%20-%20Social.pngDealInsightCampaignLVCCRCNJSocialDealInsightCampaignLVCCRCNJSocialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Vax%20Trials%20-%20Emmes.png2024VaxTrialsEmmes2024VaxTrialsEmmeshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20ActiGraph%20(1).pngDealInsightTombstoneActiGraph1DealInsightTombstoneActiGraph1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2.pngDealInsightCampaignMyonexCreapharmSocialV2DealInsightCampaignMyonexCreapharmSocialV2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Anju%20%2B%20Valsoft.pngDealInsightTombstoneAnjuValsoftDealInsightTombstoneAnjuValsofthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deep%206%20AITempus%20(315%20x%20315%20px).pngDeep6AITempus315x315pxDeep6AITempus315x315pxhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sized.pngDealInsightCampaignTombstoneAlphaIRBSabaiGlobalSocialSizedDealInsightCampaignTombstoneAlphaIRBSabaiGlobalSocialSizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Client%20Testimonials.jpegClientTestimonialsClientTestimonialshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024-ModularDevices-Flow.png2024ModularDevicesFlow2024ModularDevicesFlowhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Yecuris%20(Social%20Sized)%20(NEW).pngDealInsightCampaignTombstoneYecurisSocialSizedNEWDealInsightCampaignTombstoneYecurisSocialSizedNEWhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCKerwin%20-%20Social.pngDealInsightCampaignLVCKerwinSocialDealInsightCampaignLVCKerwinSocial2024-12-31https://www.crosstreecapital.com/deals/gentiae-raised-16m-in-series-b-preferred-shares-from-bay-city-capital-and-cibc-january-3-20072024-12-31https://www.crosstreecapital.com/insights/events/tri-con2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-october-20242024-11-26https://www.crosstreecapital.com/deals/datalabs-acquired-broadpeak-november-7-20052024-12-31https://www.crosstreecapital.com/insights/events/jpm2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-february-20202024-02-14https://www.crosstreecapital.com/deals/pbi-financial-advisory2024-12-31https://www.crosstreecapital.com/deals/primus-corporation-acquired-by-trinity-biotech-july-21-20052024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-20202024-02-14https://www.crosstreecapital.com/videos2024-01-09https://www.crosstreecapital.com/market-map/theprismdoctrinehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Innovations-Book-Feature-Image-for-website-1-scaled.jpgInnovationsBookFeatureImageforwebsite1scaledInnovationsBookFeatureImageforwebsite1scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Prism-1800x1200.jpgPrism1800x1200Prism1800x12002024-01-09https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-development-bluebook-march-20252025-04-14https://www.crosstreecapital.com/deals/longuevue-capital-partners-acquires-majority-stake-in-summit-clinical-research-to-accelerate-smo-iro-growth2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-20232024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-march-20212024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-20232024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-may-20222024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-20212024-02-14https://www.crosstreecapital.com/article/surfing-the-wave-the-patient-data-puzzlehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Arrows_Orange2.jpgArrowsOrange2ArrowsOrange2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/NewArticle-2.pngNewArticle2NewArticle2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Feb-2021-Content.pngFeb2021ContentFeb2021Content2024-01-09https://www.crosstreecapital.com/deals/arrowhead-acquired-by-medco-july-28-20112024-12-31https://www.crosstreecapital.com/deals/clinchoice-acquires-cromsource-to-expand-cro-capabilities-globally2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-20232024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-december-20242025-01-21https://www.crosstreecapital.com/insights/events/thanks/sitc2024-11-01https://www.crosstreecapital.com/insights/events/acg-florida-capital-connection2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-20242024-10-17https://www.crosstreecapital.com/careers/directorplatformhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/deal-size-pie-chart-02-768x538-1.jpgdealsizepiechart02768x5381dealsizepiechart02768x5381https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Advisor%20Execution%20Team.jpgAdvisorExecutionTeamAdvisorExecutionTeamhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/ownership-pie-chart2-768x538-1.jpgownershippiechart2768x5381ownershippiechart2768x5381https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Rocket.jpgRocketRockethttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Director%20Platform%20Top.jpgDirectorPlatformTopDirectorPlatformTophttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Director%20Platform%20-%20SME.jpgDirectorPlatformSMEDirectorPlatformSMEhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/crosstree-heatmap-worldwide-768x538.jpgcrosstreeheatmapworldwide768x538crosstreeheatmapworldwide768x5382024-12-31https://www.crosstreecapital.com/deals/pmi-preclinical-was-acquired-by-covance-a-subsidiary-of-labcorp-october-20182024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-20202024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-june-20192024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-december-2019-22024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-june-20202024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-20202024-02-14https://www.crosstreecapital.com/deals/accel-research-sites-network-acquired-by-alcanza-clinical-research-a-portfolio-company-of-martis-capital-to-expand-its-clinical-trial-site-network-and2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-august-20242024-10-17https://www.crosstreecapital.com/insights/events/thanks/beckers-healthcare-health-it-digital-health-rcm-conference2024-08-28https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-april-20222024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-20222024-02-14https://www.crosstreecapital.com/insights/events/lp/tri-con2024-11-15https://www.crosstreecapital.com/deals/radiant-research-acquired-by-icici-venture-june-8-20072024-12-31https://www.crosstreecapital.com/insights/events/thanks/pharma-ci-conference2024-09-23https://www.crosstreecapital.com/deals/access-medical-labs-allies-with-grupo-diagnostico-aries-to-expand-diagnostic-lab-capabilities-into-north-america2024-12-31https://www.crosstreecapital.com/insights/events/sitc2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-supply-chain-bluebook-march-20252025-04-16https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-february-20192024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-april-20242024-05-09https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-192024-02-14https://www.crosstreecapital.com/insights/events/lp/ashg-annual-meeting2024-10-01https://www.crosstreecapital.com/white-paper2024-07-29https://www.crosstreecapital.com/abouthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/videos/hedgehog_2-2.mp4/medium.jpghedgehog_2-2hedgehog_2-2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/videos/hedgehog_2-2.mp425nonohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_excellence.svgiconexcellenceiconexcellencehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_outcome.svgiconoutcomeiconoutcomehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_authentic.svgiconauthenticiconauthentichttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract.jpgcrosstreebgabstractcrosstreebgabstracthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/About%20-%20Envisioned%20Future.jpegAboutEnvisionedFutureAboutEnvisionedFuture2024-12-31https://www.crosstreecapital.com/deals/martec-acquired-by-nostrum-december-20-20062024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-20212024-02-14https://www.crosstreecapital.com/deals/fountain-medical-development-fmd-merged-with-kl-consulting-services-september-1-20142024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-april-20192024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-june-20212024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-november-20192024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-june-20202024-02-14https://www.crosstreecapital.com/deals/alpha-irb-acquired-by-sabai-global-a-portfolio-company-of-thompson-street-capital-to-expand-irb-capabilities2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-drug-development-bluebook-january-20252025-02-24https://www.crosstreecapital.com/careers/lifeatcrosstreehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Lifestyle.jpgLifestyleLifestylehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Our%20Team.jpgOurTeamOurTeamhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Sports.jpgSportsSportshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/growing.jpggrowinggrowinghttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/active.jpgactiveactivehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Thriving.jpgThrivingThrivinghttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/best-beaches.jpgbestbeachesbestbeacheshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Life%20at%20Crosstree.jpgLifeatCrosstreeLifeatCrosstree2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-20212024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-bluebook-february-20192024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-supply-chain-bluebook-december-20242025-01-21https://www.crosstreecapital.com/insights/events/thanks/himss2025-01-08https://www.crosstreecapital.com/deals/accelrys-acquired-qumas-december-9-20132024-12-31https://www.crosstreecapital.com/focus/diagnostics-and-toolshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20MoledcularMD%20-%20ICON.png2024MoledcularMDICON2024MoledcularMDICONhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20BBIIBEX.pngDealInsightCampaignTombstoneBBIIBEXDealInsightCampaignTombstoneBBIIBEXhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20PhenoPath%20-%20Quest%20Diagnostics%20(1).png2024PhenoPathQuestDiagnostics12024PhenoPathQuestDiagnostics1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Zebrasci%20-%20BD.png2024ZebrasciBD2024ZebrasciBDhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Pyxant%20Labs%20-%20ArchiMed.png2024PyxantLabsArchiMed2024PyxantLabsArchiMedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Access%20-%20Aries.png2024AccessAries2024AccessArieshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20OpGen%20-%20Curetis.png2024OpGenCuretis2024OpGenCuretishttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Grant%20Avenue%20-%20Creo.png2024GrantAvenueCreo2024GrantAvenueCreohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_brain.svgiconbrainiconbrainhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Expertise-D&T.jpgExpertiseDTExpertiseDThttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Transposagen%20-%20Lonza.png2024TransposagenLonza2024TransposagenLonzahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/D&T%20-%20BlueBook.jpegDTBlueBookDTBlueBookhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20QDX%20-%20Hadley%20-%20LabGenomics.png2024QDXHadleyLabGenomics2024QDXHadleyLabGenomicshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_heart-hands.svgiconhearthandsiconhearthandshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Pyxant%20Labs%20-%20Covance.png2024PyxantLabsCovance2024PyxantLabsCovancehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Versiti%20-%20Quantizen.png2024VersitiQuantizen2024VersitiQuantizenhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/AdobeStock_660603214.jpegAdobeStock660603214AdobeStock660603214https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20HistoGeneX%20-%20Arsenal.png2024HistoGeneXArsenal2024HistoGeneXArsenalhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_clipboard-1.svgiconclipboard1iconclipboard1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Santus%20-%20DermaRite.png2024SantusDermaRite2024SantusDermaRitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20sengenics%20(2).pngDealInsightTombstonesengenics2DealInsightTombstonesengenics2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Santus%20-%20Reliable.png2024SantusReliable2024SantusReliablehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Biotechne.pngDealInsightTombstoneBiotechneDealInsightTombstoneBiotechnehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Haematologic%20Technologies%20-%20Edgewater.png2024HaematologicTechnologiesEdgewater2024HaematologicTechnologiesEdgewaterhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Grenova%20-%20Peloton.png2024GrenovaPeloton2024GrenovaPelotonhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_heart.svgiconhearticonhearthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Prevention%20Genetics%20-%20Exact%20Sciences.png2024PreventionGeneticsExactSciences2024PreventionGeneticsExactSciences2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-december-20202024-02-14https://www.crosstreecapital.com/video/industry-leaders-panel-discussion-patient-access-organizations2024-09-24https://www.crosstreecapital.com/deals/mpulse-mobile-acquired-message-beam-june-20182024-12-31https://www.crosstreecapital.com/insights/events/lp/jpm2024-11-01https://www.crosstreecapital.com/insights/events/lp/slas2024-11-15https://www.crosstreecapital.com/deals/gentris-acquired-by-cancer-genetics-july-21-20142024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-october-20212024-02-14https://www.crosstreecapital.com/deals/viactiv-acquired-by-adare-and-tpg2024-12-31https://www.crosstreecapital.com/subscribehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/banner_subscribe.jpgbannersubscribebannersubscribe2024-08-09https://www.crosstreecapital.com/deals/trifecta-clinical-was-acquired-by-wcg2024-12-31https://www.crosstreecapital.com/case-study/crosstree-helps-archimed-create-early-drug-development-platform-through-three-way-acquisitionhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpgcrosstreeogimageJan0220240439574666PMcrosstreeogimageJan0220240439574666PM2024-01-09https://www.crosstreecapital.com/insights/events/lp2024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-november-20202024-02-14https://www.crosstreecapital.com/deals/ccrc-recapitalized-by-martis-capital-via-its-newly-formed-clinical-research-site-platform-alcanza-clinical-research2024-12-31https://www.crosstreecapital.com/insights/events/thanks/asmebias-axs25-summit2025-03-19https://www.crosstreecapital.com/deals/histogenex-combines-with-caprion-biosciences-via-strategic-investment-from-arsenal-capital-partners2024-12-31https://www.crosstreecapital.com/insights/events/thanks/cns-summit2024-11-01https://www.crosstreecapital.com/insights/events/thanks/ahima-24-conference2024-09-23https://www.crosstreecapital.com/deals/gsk-sold-assets-to-combe2024-12-31https://www.crosstreecapital.com/insights/events/lp/amp-annual-meeting-and-expo2024-11-18https://www.crosstreecapital.com/insights/events/thanks/dcat-week2025-02-11https://www.crosstreecapital.com/deals/cri-worldwide-acquired-by-sv-life-sciences-october-3-20072024-12-31https://www.crosstreecapital.com/deals/imp-logistics-acquired-by-pra-and-genstar-capital-llc-march-4-2013-22024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-20222024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-september-20242024-11-04https://www.crosstreecapital.com/deals/pinnacle-clinical-research-a-portfolio-company-of-longvue-capital-acquires-kerwin-medical-center-to-bolster-clinical-trial-site-network-and-trial-execution-capabilities2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-may-20242024-06-17https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-20232024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-february-20232024-02-14https://www.crosstreecapital.com/insights/events/lp/sot2024-11-15https://www.crosstreecapital.com/insights/events/thanks/world-vaccine-congress2025-04-08https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-supply-chain-bluebook-november-20242025-01-06https://www.crosstreecapital.com/deals/bbi-solutions-a-portfolio-company-of-novo-holdings-acquired-ibex-technologies-inc2024-12-31https://www.crosstreecapital.com/insights/events/thanks/aaps-national-biotechnology-conference2025-03-19https://www.crosstreecapital.com/deals/realtime-software-solutions-receives-strategic-investment-from-llr-partners-to-accelerate-growth-and-product-innovation2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-april-20212024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-20202024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-december-20222024-02-14https://www.crosstreecapital.com/insights/events/lp/aaps-national-biotechnology-conference2025-03-19https://www.crosstreecapital.com/deals/bio-techne-divested-assets-of-its-subsidiary-atlanta-biologicals-to-geminibio2025-01-09https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-march-20192024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-20222024-02-14https://www.crosstreecapital.com/deals/firstsource-laboratory-solutions-acquired-by-labcorp-september-14-20102024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-december-2019-22024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-march-20242024-04-12https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-bluebook-february-20252025-03-26https://www.crosstreecapital.com/deals/invivodata-acquired-by-ert-and-genstar-capital-llc-july-9-20122024-12-31https://www.crosstreecapital.com/insights/events/thanks/cphi-worldwide2024-08-29https://www.crosstreecapital.com/deals/protocol-first-joins-flatiron-health-to-help-bridge-the-gap-between-real-world-care-and-clinical-research2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-bluebook-november-20242025-01-10https://www.crosstreecapital.com/insights/events/thanks/wrib2025-03-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-august-20202024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-20242024-11-26https://www.crosstreecapital.com/deals/critical-path-service-acquired-by-knoell-june-13-20132024-12-31https://www.crosstreecapital.com/insights/events/lp/acg-florida-capital-connection2024-11-12https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-bluebook-january-20252025-02-28https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-20212024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-december-20242025-01-21https://www.crosstreecapital.com/deals/sabai-global-acquired-by-thompson-street-capital-partners-to-accelerate-ibc-and-irb-growth2024-12-31https://www.crosstreecapital.com/deals/ancora-acquired-by-corden-pharma-november-12-20132024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-july-2024-crosstree2024-09-05https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-december-20212024-02-14https://www.crosstreecapital.com/deals/romark-laboratories-amount-raised-undisclosed2024-12-31https://www.crosstreecapital.com/deals/chemo-assets-acquired-by-ducere-pharma2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-may-20212024-02-14https://www.crosstreecapital.com/deals/sigmacare-acquired-by-homecare-crm-march-10-20152024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-october-20202024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-august-20202024-02-14https://www.crosstreecapital.com/newsroom/crosstree-continues-rapid-expansion-with-first-chief-marketing-and-growth-officer-and-three-new-directorshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_98249666-scaled-1.jpegAdobeStock98249666scaled1AdobeStock98249666scaled1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(81)-1.pngUntitleddesign811Untitleddesign8112024-01-09https://www.crosstreecapital.com/deals/clinical-site-services-acquired-by-american-clinical-research-services-to-add-tech-enabled-patient-recruitment-capabilities2024-12-31https://www.crosstreecapital.com/case-study2024-01-08https://www.crosstreecapital.com/insights/events/lp/vive2025-01-08https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-august-20212024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-20212024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-20222024-02-14https://www.crosstreecapital.com/deals/ssi-strategy-a-portfolio-company-of-amulet-capital-partners-acquired-nda-group-ab-to-bolster-regulatory-affairs-consulting-capabilities-and-expand-int2024-12-31https://www.crosstreecapital.com/insights/events/lp/acmg2025-02-11https://www.crosstreecapital.com/about/team/jasonlayton2025-04-15https://www.crosstreecapital.com/videos/future-of-clinical-trialshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/no-challenges-thumbnail.jpgnochallengesthumbnailnochallengesthumbnailhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Cimino-Still-2.pngRickCiminoStill2RickCiminoStill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Gens-still-2.pngSteveGensstill2SteveGensstill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Sullivan-still-2.pngSteveSullivanstill2SteveSullivanstill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdark2024-01-09https://www.crosstreecapital.com/deals/benchmark-research-acquired-by-iqvia-combined-with-avacare-to-expand-vaccine-and-clinical-trial-site-capabilities2024-12-31https://www.crosstreecapital.com/insights/events/scope-summit2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-20202024-02-14https://www.crosstreecapital.com/deals/semorex-acquired-by-myos-corporation2024-12-31https://www.crosstreecapital.com/insights/events/lp/dealmax2025-02-10https://www.crosstreecapital.com/bluebooks/pharma-services-pharma-technology-bluebook-march-20252025-04-22https://www.crosstreecapital.com/insights/events/lp/himss2025-01-08https://www.crosstreecapital.com/insightshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-01T154859.733.pngUntitleddesign20250401T154859733Untitleddesign20250401T154859733https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstre_Tombstone_Infographic_Pyxant_Labcorp-2.pngCrosstreTombstoneInfographicPyxantLabcorp2CrosstreTombstoneInfographicPyxantLabcorp2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Benchmark-v2-2.pngCrosstreeTombstoneInfographicBenchmarkv22CrosstreeTombstoneInfographicBenchmarkv22https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Pharmasol-smaller.jpgCrosstreeTombstoneInfographicPharmasolsmallerCrosstreeTombstoneInfographicPharmasolsmallerhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1752872030-1800x1200.jpgshutterstock17528720301800x1200shutterstock17528720301800x1200https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-26T112246.466.pngUntitleddesign20250226T112246466Untitleddesign20250226T112246466https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1054265696_small.jpgshutterstock1054265696smallshutterstock1054265696smallhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_469364276-A-1.jpgAdobeStock469364276A1AdobeStock469364276A1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/white-papers/Inorganic-Growth-Strategies-in-Precision-Medicine-White-Paper-Cover.jpegInorganicGrowthStrategiesinPrecisionMedicineWhitePaperCoverInorganicGrowthStrategiesinPrecisionMedicineWhitePaperCoverhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/crosstree-tombstone-infographic-thumbnail-2.pngcrosstreetombstoneinfographicthumbnail2crosstreetombstoneinfographicthumbnail2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-42-06-5457-PM.jpgcrosstreeogimageJan0220240442065457PMcrosstreeogimageJan0220240442065457PMhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-13T113514.444.pngUntitleddesign20250313T113514444Untitleddesign20250313T113514444https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-3.pngUntitleddesign3Untitleddesign3https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1348356479-B.jpgshutterstock1348356479Bshutterstock1348356479Bhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Arrows_Orange2.jpgArrowsOrange2ArrowsOrange2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-17T150049.946.pngUntitleddesign20250317T150049946Untitleddesign20250317T150049946https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-26T103716.855.pngUntitleddesign20241126T103716855Untitleddesign20241126T103716855https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1014555526-A.jpgshutterstock1014555526Ashutterstock1014555526Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_238307387-C.jpgAdobeStock238307387CAdobeStock238307387Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_46595127.jpgAdobeStock46595127AdobeStock46595127https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1348356479-B-1.jpgshutterstock1348356479B1shutterstock1348356479B1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-28T173343.495.pngUntitleddesign20250228T173343495Untitleddesign20250228T173343495https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(64).pngUntitleddesign64Untitleddesign64https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(72).pngUntitleddesign72Untitleddesign72https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Copy-of-Untitled-Design.pngCopyofUntitledDesignCopyofUntitledDesignhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-42.pngUntitleddesign42Untitleddesign42https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_201606393-1800x1013.jpegAdobeStock2016063931800x1013AdobeStock2016063931800x1013https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-04T165415.322.pngUntitleddesign20241104T165415322Untitleddesign20241104T165415322https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Grenova-Infographic-Image.pngGrenovaInfographicImageGrenovaInfographicImagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/white-papers/Positioning-Biobanking-Assets-for-Maximum-Value-Cover.jpegPositioningBiobankingAssetsforMaximumValueCoverPositioningBiobankingAssetsforMaximumValueCoverhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/images13.jpgimages13images13https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Copy-of-Untitled-Design-3.pngCopyofUntitledDesign3CopyofUntitledDesign3https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_ZebraSci-2-scaled.jpgCrosstreeTombstoneInfographicZebraSci2scaledCrosstreeTombstoneInfographicZebraSci2scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/PreventionGenetics-Infographic.pngPreventionGeneticsInfographicPreventionGeneticsInfographichttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-04T092707.128.pngUntitleddesign20240904T092707128Untitleddesign20240904T092707128https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(43).pngUntitleddesign43Untitleddesign43https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-14T103931.881.pngUntitleddesign20250414T103931881Untitleddesign20250414T103931881https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_238307387-A.jpgAdobeStock238307387AAdobeStock238307387Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-04T164958.577.pngUntitleddesign20241104T164958577Untitleddesign20241104T164958577https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1348356479-D.jpgshutterstock1348356479Dshutterstock1348356479Dhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Protocol-First_Infographic-01-1-scaled.jpgCrosstreeProtocolFirstInfographic011scaledCrosstreeProtocolFirstInfographic011scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-51.pngUntitleddesign51Untitleddesign51https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1351392818-A.jpgshutterstock1351392818Ashutterstock1351392818Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-26T102948.498.pngUntitleddesign20241126T102948498Untitleddesign20241126T102948498https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/graph-Jan-02-2024-04-42-10-7464-PM.jpggraphJan0220240442107464PMgraphJan0220240442107464PMhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Copy-of-Untitled-Design-1.pngCopyofUntitledDesign1CopyofUntitledDesign1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/BBK-Infographic.pngBBKInfographicBBKInfographichttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Insight-Campaign-Infographic-Versiti.pngDealInsightCampaignInfographicVersitiDealInsightCampaignInfographicVersitihttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/BB%20D&T%20-%20February%202024.pngBBDTFebruary2024BBDTFebruary2024https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Thumbnail%20Modular%20Devices%20Deal%20Insight.pngThumbnailModularDevicesDealInsightThumbnailModularDevicesDealInsighthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1884612880-B.jpgshutterstock1884612880Bshutterstock1884612880Bhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/graph-Jan-02-2024-04-40-03-6178-PM.jpggraphJan0220240440036178PMgraphJan0220240440036178PMhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-26T160935.661.pngUntitleddesign20250326T160935661Untitleddesign20250326T160935661https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/DT-July-BB-Website-Image.pngDTJulyBBWebsiteImageDTJulyBBWebsiteImagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1549204658-scaled.jpgshutterstock1549204658scaledshutterstock1549204658scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Cimino-Still-2.pngRickCiminoStill2RickCiminoStill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_233911676-1800x1200.webpAdobeStock2339116761800x1200AdobeStock2339116761800x1200https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Navitas_Infographic-v2-featured-image-1.pngCrosstreeNavitasInfographicv2featuredimage1CrosstreeNavitasInfographicv2featuredimage1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1348356479-A.jpgshutterstock1348356479Ashutterstock1348356479Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(50).pngUntitleddesign50Untitleddesign50https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_ClinChoice-01.pngCrosstreeTombstoneInfographicClinChoice01CrosstreeTombstoneInfographicClinChoice01https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpgcrosstreeogimageJan0220240439574666PMcrosstreeogimageJan0220240439574666PMhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Campaign-Infographic-VaxTRIALS-Social-Sized.pngDealCampaignInfographicVaxTRIALSSocialSizedDealCampaignInfographicVaxTRIALSSocialSizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-43.pngUntitleddesign43Untitleddesign43https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Ascent-Pharmalex.pngAscentPharmalexAscentPharmalexhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-26T112228.581.pngUntitleddesign20250226T112228581Untitleddesign20250226T112228581https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/BCT-Deal-Infographic-Featured-Image.pngBCTDealInfographicFeaturedImageBCTDealInfographicFeaturedImagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-22T150033.284.pngUntitleddesign20250422T150033284Untitleddesign20250422T150033284https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/crosstree-og-image-Jan-02-2024-04-39-57-4666-PM.jpegcrosstreeogimageJan0220240439574666PMcrosstreeogimageJan0220240439574666PMhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Copy-of-Untitled-Design-2.pngCopyofUntitledDesign2CopyofUntitledDesign2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-21T083007.436.pngUntitleddesign20250121T083007436Untitleddesign20250121T083007436https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_534465133-3.jpgshutterstock5344651333shutterstock5344651333https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-12-30T172014.577.pngUntitleddesign20241230T172014577Untitleddesign20241230T172014577https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Open-Clinica_Infographic-1.pngCrosstreeOpenClinicaInfographic1CrosstreeOpenClinicaInfographic1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(40).pngUntitleddesign40Untitleddesign40https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_IRB_Infographic_vF.pngCrosstreeIRBInfographicvFCrosstreeIRBInfographicvFhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_94798635-1.jpgAdobeStock947986351AdobeStock947986351https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-31T132859.166.pngUntitleddesign20250331T132859166Untitleddesign20250331T132859166https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-16T110543.792.pngUntitleddesign20250416T110543792Untitleddesign20250416T110543792https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Catalyst-Genpro.pngCrosstreeTombstoneInfographicCatalystGenproCrosstreeTombstoneInfographicCatalystGenprohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/CSSi-PAG-Infographic-featured-image.pngCSSiPAGInfographicfeaturedimageCSSiPAGInfographicfeaturedimagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Sullivan-still-2.pngSteveSullivanstill2SteveSullivanstill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1351392818-B.jpgshutterstock1351392818Bshutterstock1351392818Bhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Thumbnail%20Alpha%20IRB%20Deal%20Insight.pngThumbnailAlphaIRBDealInsightThumbnailAlphaIRBDealInsighthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Campaign-Infographic-SSI-Strategy-Social-Sized.pngDealCampaignInfographicSSIStrategySocialSizedDealCampaignInfographicSSIStrategySocialSizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1348356479-C.jpgshutterstock1348356479Cshutterstock1348356479Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Campaign-Infographic-QDx-Social-Sized.pngDealCampaignInfographicQDxSocialSizedDealCampaignInfographicQDxSocialSizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_CCRC-01.jpgCrosstreeTombstoneInfographicCCRC01CrosstreeTombstoneInfographicCCRC01https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Pharma%20Blue%20Book%20-%20February%202024.jpgPharmaBlueBookFebruary2024PharmaBlueBookFebruary2024https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_469364276-B.jpgAdobeStock469364276BAdobeStock469364276Bhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Innovations-Book-Feature-Image-for-website-1-scaled.jpgInnovationsBookFeatureImageforwebsite1scaledInnovationsBookFeatureImageforwebsite1scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-03T122043.440.pngUntitleddesign20250303T122043440Untitleddesign20250303T122043440https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(2)-1.pngUntitleddesign21Untitleddesign21https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Untitled-design-22.pngUntitleddesign22Untitleddesign22https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1014555526-B.jpgshutterstock1014555526Bshutterstock1014555526Bhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1884612880-A.jpgshutterstock1884612880Ashutterstock1884612880Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Sabai-Infographic_featured-image.pngSabaiInfographicfeaturedimageSabaiInfographicfeaturedimagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_CTT-scaled.jpgCrosstreeTombstoneInfographicCTTscaledCrosstreeTombstoneInfographicCTTscaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(46)-1.pngUntitleddesign461Untitleddesign461https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1351392818-D.jpgshutterstock1351392818Dshutterstock1351392818Dhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-10-17T145851.189.pngUntitleddesign20241017T145851189Untitleddesign20241017T145851189https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_423930893-C.jpgAdobeStock423930893CAdobeStock423930893Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(69).pngUntitleddesign69Untitleddesign69https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_UpStream-1.jpgCrosstreeTombstoneInfographicUpStream1CrosstreeTombstoneInfographicUpStream1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Gens-still-2.pngSteveGensstill2SteveGensstill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(10).pngUntitleddesign10Untitleddesign10https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-10-15T150559.010.pngUntitleddesign20241015T150559010Untitleddesign20241015T150559010https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/PS-July-BB-Website-Image.pngPSJulyBBWebsiteImagePSJulyBBWebsiteImagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20(1200%20x%201200%20px)%20(1).pngUntitled1200x1200px1Untitled1200x1200px1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/deal.pngdealdealhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Campaign-Infographic-Versiti-Pearl-Pathways-Social-Sized.pngDealCampaignInfographicVersitiPearlPathwaysSocialSizedDealCampaignInfographicVersitiPearlPathwaysSocialSizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/ROI%20Healthcare%20Deal%20Featured%20Image%20(1).pngROIHealthcareDealFeaturedImage1ROIHealthcareDealFeaturedImage1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_469364276-A.jpgAdobeStock469364276AAdobeStock469364276Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(49).pngUntitleddesign49Untitleddesign49https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Pharmica-scaled.jpgCrosstreeTombstoneInfographicPharmicascaledCrosstreeTombstoneInfographicPharmicascaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-21T083456.357.pngUntitleddesign20250121T083456357Untitleddesign20250121T083456357https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Whitepaper%20PAO%20-%20Website%20Thumbnail%20Image.pngWhitepaperPAOWebsiteThumbnailImageWhitepaperPAOWebsiteThumbnailImagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(19)-1.pngUntitleddesign191Untitleddesign191https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-05T092022.185.pngUntitleddesign20240905T092022185Untitleddesign20240905T092022185https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-53.pngUntitleddesign53Untitleddesign53https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(26).pngUntitleddesign26Untitleddesign26https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Campaign-Infographic-GrantCREO-Social-Sized.pngDealCampaignInfographicGrantCREOSocialSizedDealCampaignInfographicGrantCREOSocialSizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_424161376-1800x1135.jpgshutterstock4241613761800x1135shutterstock4241613761800x1135https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(42).pngUntitleddesign42Untitleddesign42https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_281211016-1800x1009.jpegAdobeStock2812110161800x1009AdobeStock2812110161800x1009https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Copy-of-Untitled-Design-4.pngCopyofUntitledDesign4CopyofUntitledDesign4https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Feb-2021-Content.pngFeb2021ContentFeb2021Contenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Lexitas-NovaQuest-Deal-Infographic_Final.pngLexitasNovaQuestDealInfographicFinalLexitasNovaQuestDealInfographicFinalhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-07T163307.697.pngUntitleddesign20250107T163307697Untitleddesign20250107T163307697https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_238307387-B.webpAdobeStock238307387BAdobeStock238307387Bhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(48).pngUntitleddesign48Untitleddesign48https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-1-1.pngUntitleddesign11Untitleddesign11https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-05T091738.213.pngUntitleddesign20240905T091738213Untitleddesign20240905T091738213https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-21T093744.809.pngUntitleddesign20250121T093744809Untitleddesign20250121T093744809https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(4)-1.pngUntitleddesign41Untitleddesign41https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-06T121211.560.pngUntitleddesign20250106T121211560Untitleddesign20250106T121211560https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_240748820-scaled.jpegAdobeStock240748820scaledAdobeStock240748820scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/no-challenges-thumbnail.jpgnochallengesthumbnailnochallengesthumbnailhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_240395963-1-1800x1200.jpegAdobeStock24039596311800x1200AdobeStock24039596311800x1200https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1014555526-C.jpgshutterstock1014555526Cshutterstock1014555526Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_280738306-C.jpgAdobeStock280738306CAdobeStock280738306Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/RMC-Deal-Infographic-Featured-Image.pngRMCDealInfographicFeaturedImageRMCDealInfographicFeaturedImagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-21T082215.822.pngUntitleddesign20250121T082215822Untitleddesign20250121T082215822https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1351392818-C.jpgshutterstock1351392818Cshutterstock1351392818Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Prism-1800x1200.jpgPrism1800x1200Prism1800x1200https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/AdobeStock_982679813.jpegAdobeStock982679813AdobeStock982679813https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(51).pngUntitleddesign51Untitleddesign51https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_299056404-A.webpAdobeStock299056404AAdobeStock299056404Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_1242847558-768x512.jpgshutterstock1242847558768x512shutterstock1242847558768x512https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-34-1.pngUntitleddesign341Untitleddesign341https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/shutterstock_534465133-4.jpgshutterstock5344651334shutterstock5344651334https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Riegel-Still-2.pngRickRiegelStill2RickRiegelStill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/NewArticle-2.pngNewArticle2NewArticle2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-26T161312.897.pngUntitleddesign20250326T161312897Untitleddesign20250326T161312897https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/PS-July-BB-Website-Image-1.pngPSJulyBBWebsiteImage1PSJulyBBWebsiteImage1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Quartesian_Summit-scaled.jpgCrosstreeTombstoneInfographicQuartesianSummitscaledCrosstreeTombstoneInfographicQuartesianSummitscaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-33.pngUntitleddesign33Untitleddesign33https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(1).pngUntitleddesign1Untitleddesign1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(29).pngUntitleddesign29Untitleddesign29https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-28T163243.240.pngUntitleddesign20250128T163243240Untitleddesign20250128T163243240https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/white-papers/Precision-and-Specialty-Medicine-Clinical-Trial-White-Paper-Cover-Image.jpegPrecisionandSpecialtyMedicineClinicalTrialWhitePaperCoverImagePrecisionandSpecialtyMedicineClinicalTrialWhitePaperCoverImagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Excel.pngCrosstreeTombstoneInfographicExcelCrosstreeTombstoneInfographicExcelhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Untitled-design-52.pngUntitleddesign52Untitleddesign52https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/LVC-and-Summit-Infographic-Featured-Image.pngLVCandSummitInfographicFeaturedImageLVCandSummitInfographicFeaturedImagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Thumbnail%20Yecuris%20Deal%20Insight.pngThumbnailYecurisDealInsightThumbnailYecurisDealInsighthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_356099396-A.webpAdobeStock356099396AAdobeStock356099396Ahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_275264857-1800x1013.webpAdobeStock2752648571800x1013AdobeStock2752648571800x1013https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree-Deal-Insight-Infographic-Featured-Image-RealTime.pngCrosstreeDealInsightInfographicFeaturedImageRealTimeCrosstreeDealInsightInfographicFeaturedImageRealTimehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Benchmark.pngCrosstreeTombstoneInfographicBenchmarkCrosstreeTombstoneInfographicBenchmarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/Thumbnail%20Continuum%20Clinical%20Deal%20Insight.pngThumbnailContinuumClinicalDealInsightThumbnailContinuumClinicalDealInsighthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_dMed_Infographic-v3-scaled.jpgCrosstreedMedInfographicv3scaledCrosstreedMedInfographicv3scaledhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_356099396-C.jpgAdobeStock356099396CAdobeStock356099396Chttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-06T120438.784.pngUntitleddesign20250106T120438784Untitleddesign20250106T120438784https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_293953008-1798x1200.jpegAdobeStock2939530081798x1200AdobeStock2939530081798x1200https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-26T160124.257.pngUntitleddesign20250326T160124257Untitleddesign20250326T160124257https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-24T143232.742.pngUntitleddesign20250224T143232742Untitleddesign20250224T143232742https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/PS-July-BB-Website-Image-2.pngPSJulyBBWebsiteImage2PSJulyBBWebsiteImage2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Campaign-Infographic-MBR-Social-Sized-1.pngDealCampaignInfographicMBRSocialSized1DealCampaignInfographicMBRSocialSized1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Crosstree_Tombstone_Infographic_Anteris-featured-image.pngCrosstreeTombstoneInfographicAnterisfeaturedimageCrosstreeTombstoneInfographicAnterisfeaturedimagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-16T103632.637.pngUntitleddesign20250416T103632637Untitleddesign20250416T1036326372024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-september-20212024-02-14https://www.crosstreecapital.com/deals/pharmastar-acquired-by-ubc-april-21-20052024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-april-20202024-02-14https://www.crosstreecapital.com/deals/ascent-and-pharmalex-merge-to-expand-clinical-development-services-in-asia2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-february-20222024-02-14https://www.crosstreecapital.com/deals/anju-software-acquired-by-valsoft-corporation-to-grow-eclinical-and-commercialization-capabilities2024-12-31https://www.crosstreecapital.com/about/team/stacey-staniszewski2025-06-06https://www.crosstreecapital.com/insights/events/lp/asmebias-axs25-summit2025-03-19https://www.crosstreecapital.com/white-paper/thank-you/white-paperpatient-access-organizations-an-emerging-ecosystem2024-07-29https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-20222024-02-14https://www.crosstreecapital.com/deals/access-regional-laboratory-business-acquired-by-labcorp-june-20172024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-january-20232024-02-14https://www.crosstreecapital.com/insights/events/ahima-24-conference2024-12-31https://www.crosstreecapital.com/deals/pharmica-consulting-acquired-by-propharma-group-to-provide-holistic-clinical-trial-execution-expertise2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-20202024-02-14https://www.crosstreecapital.com/deals/beacon-bioscience-acquired-by-icon-july-1-20042024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-january-20222024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-development-bluebook-january-20252025-02-24https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-20212024-02-14https://www.crosstreecapital.com/insights/events/lp/snmmi2025-01-08https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-2024-crosstree2024-09-05https://www.crosstreecapital.com/insights/events/amp-annual-meeting-and-expo2024-12-31https://www.crosstreecapital.com/market-map/innovations-in-pharmaceutical-developmenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Prism-1800x1200.jpgPrism1800x1200Prism1800x1200https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Innovations-Book-Feature-Image-for-website-1-scaled.jpgInnovationsBookFeatureImageforwebsite1scaledInnovationsBookFeatureImageforwebsite1scaled2024-01-09https://www.crosstreecapital.com/deals/pyxant-labs-receives-majority-investment-from-archimed2024-12-31https://www.crosstreecapital.com/deals/imedex-acquired-by-amerisourcebergen-may-10-20042024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-august-20232024-02-14https://www.crosstreecapital.com/deals/ixion-biotechnology-inc-financial-advisory2024-12-31https://www.crosstreecapital.com/insights/events/thanks/rsna2024-11-15https://www.crosstreecapital.com/deals/plethico-acquired-natrol-december-28-20072024-12-31https://www.crosstreecapital.com/insights/events/lp/aaps2024-10-01https://www.crosstreecapital.com/deals/myonex-acquired-saveway-compounding-pharmacy2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-january-20212024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-20232024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-20202024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharmaceutical-commerce-bluebook-january-20252025-02-26https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-june-20192024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-pharma-technology-bluebook-february-20252025-03-31https://www.crosstreecapital.com/insights/events/lp/rsna2024-11-15https://www.crosstreecapital.com/deals/jubilant-organosys-ltd-acquired-target-research-associates-october-5-20052024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-july-20202024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-october-192024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-november-20222024-02-14https://www.crosstreecapital.com/insights/events/lp/bio-it-world-venture2025-02-11https://www.crosstreecapital.com/deals/predictive-biosciences-anatomic-pathology-business-acquired-by-miraca-life-sciences-november-19-20122024-12-31https://www.crosstreecapital.com/deals/candescent-healing-acquired-by-candescent-partners2024-12-31https://www.crosstreecapital.com/deals/idt-acquired-the-oligo-manufacturing-business-of-geneworks-february-8-20172024-12-31https://www.crosstreecapital.com/insights/events/dcat-week2025-02-11https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-sept-2019-22024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-bluebook-march-20192024-02-14https://www.crosstreecapital.com/careershttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/videos/Crosstree%20Recruitment%20Video%20V5.mp4/medium.jpgCrosstree Recruitment Video V5Crosstree Recruitment Video V5https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/videos/Crosstree%20Recruitment%20Video%20V5.mp4225nonohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Marvin-Best_tie_color_for-website.jpgMarvinBesttiecolorforwebsiteMarvinBesttiecolorforwebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Life%20at%20Crosstree.jpgLifeatCrosstreeLifeatCrosstreehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Authenticity.jpegAuthenticityAuthenticityhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Exceptional%20Outcomes.jpgExceptionalOutcomesExceptionalOutcomeshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Jason-Layton-Website.jpgJasonLaytonWebsiteJasonLaytonWebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Anne-Juarez-website.jpgAnneJuarezwebsiteAnneJuarezwebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Careers%20Homepage.jpgCareersHomepageCareersHomepagehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Dominic-Stockey-Website.jpgDominicStockeyWebsiteDominicStockeyWebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Director%20Platform%20Top.jpgDirectorPlatformTopDirectorPlatformTophttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Excellence.jpgExcellenceExcellencehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Jeff-Ellis-Website.jpgJeffEllisWebsiteJeffEllisWebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdark2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-20202024-02-14https://www.crosstreecapital.com/insights/events/thanks/tri-con2024-11-15https://www.crosstreecapital.com/insights/events/thanks/amp-annual-meeting-and-expo2024-11-18https://www.crosstreecapital.com/deals/wcg-leonardgreenpartners2024-12-31https://www.crosstreecapital.com/deals/pyxant-labs-bolsters-capabilities-in-acquisition-of-covance-by-labcorps-slc-bioanalytical-site2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-20212024-02-14https://www.crosstreecapital.com/about/team/gordonryerson2025-04-15https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-20192024-02-14https://www.crosstreecapital.com/deals/baylor-college-of-medicine-bdc-assets-acquired-by-cell-medica-june-17-20162024-12-31https://www.crosstreecapital.com/article2024-01-03https://www.crosstreecapital.com/deals/ipeople-acquired-by-rldatix-a-portfolio-company-of-five-arrows-and-ta-associates2025-03-17https://www.crosstreecapital.com/insights/events/thanks/dia-eu2025-02-11https://www.crosstreecapital.com/deals/biocor-acquired-by-ubc-november-6-20062024-12-31https://www.crosstreecapital.com/insights/events/bio-it-world-venture2025-02-11https://www.crosstreecapital.com/insights/events/world-vaccine-congress-europe2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-february-20212024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-june-20242024-07-25https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-20212024-02-14https://www.crosstreecapital.com/deals/scandius-biomedical-amount-raised-undisclosed-preferred-equity-placement-agent2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-20242024-07-25https://www.crosstreecapital.com/deals/versiti-acquired-pearl-pathways-to-expand-clinical-trial-services-capabilities2024-12-31https://www.crosstreecapital.com/insights/events/cphi-worldwide2024-12-31https://www.crosstreecapital.com/deals/santus-laboratories-owned-by-healthedge-partners-was-purchased-by-dermarite-owned-by-tailwind-capital-group-august-20182024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-january-20222024-02-14https://www.crosstreecapital.com/deals/sunlink-sold-assets-to-cvs-health2024-12-31https://www.crosstreecapital.com/deals/centralcoast-pathology-laboratory-business-acquired-by-sonic-healthcare-february-7-20112024-12-31https://www.crosstreecapital.com/deals/clinical-pharmacology-associates-acquired-by-sfbc-international-august-4-2003-22024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharmaceutical-commerce-bluebook-february-20252025-03-26https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharmaceutical-commerce-bluebook-december-20242025-01-21https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-may-20202024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-20222024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-august-20212024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-june-20222024-02-14https://www.crosstreecapital.com/deals/preventiongenetics-acquired-by-exact-sciences-to-enable-earlier-cancer-detection-and-hereditary-cancer-testing2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-january-20252025-02-26https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-march-20202024-02-14https://www.crosstreecapital.com/deals/vaxtrials-acuired-by-emmes2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-bluebook-december-20242025-01-21https://www.crosstreecapital.com/insights/events/dia-eu2025-02-11https://www.crosstreecapital.com/insights/events/lp/cphi-americas2025-03-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-20242024-06-17https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-20222024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-june-20242024-07-26https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-20212024-02-14https://www.crosstreecapital.com/insights/events/thanks/dpharm2024-08-28https://www.crosstreecapital.com/insights/events/thanks/ashg-annual-meeting2024-10-01https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-november-20242025-01-06https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-20232024-02-14https://www.crosstreecapital.com/deals/bbk-worldwide-acquired-by-publicis-health-to-expand-clinical-trial-expertise-with-proprietary-technology-and-patient-centric-solutions2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-august-20242024-10-15https://www.crosstreecapital.com/videos/innovations-role-in-life-sciences-with-rick-riegelhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Cimino-Still-2.pngRickCiminoStill2RickCiminoStill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Sullivan-still-2.pngSteveSullivanstill2SteveSullivanstill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Gens-still-2.pngSteveGensstill2SteveGensstill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Riegel-Still-2.pngRickRiegelStill2RickRiegelStill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdark2024-01-09https://www.crosstreecapital.com/insights/events/asmebias-axs25-summit2025-03-19https://www.crosstreecapital.com/deals/anteris-acquired-by-kymanox-a-portfolio-company-of-westview-capital-partners-to-expand-injectable-combination-product-development-capabilities-globall2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-april-20202024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-november-20212024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-january-20212024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-july-20192024-02-14https://www.crosstreecapital.com/deals/durbin-acquired-pharmaceutical-trade-services-inc-ptsi-december-1-20142024-12-31https://www.crosstreecapital.com/insights/events/world-vaccine-congress2025-04-08https://www.crosstreecapital.com/insights/events/lp/aacr2025-02-10https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharmaceutical-commerce-bluebook-november-20242025-01-06https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-sept-2019-22024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-march-20212024-02-14https://www.crosstreecapital.com/deals/medsphere-raised-12000000-of-senior-debt2024-12-31https://www.crosstreecapital.com/insights/events/rsna2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-august-20232024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-march-20192024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-march-20212024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-20212024-02-14https://www.crosstreecapital.com/insights/events/thanks/aacr2025-02-10https://www.crosstreecapital.com/deals/intrinsic-clinical-systems-acquired-by-propharma-group2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-july-20192024-02-14https://www.crosstreecapital.com/deals/gsk-sold-assets-to-lil-drug-store2024-12-31https://www.crosstreecapital.com/deals/qdx-pathology-a-portfolio-company-of-hadley-capital-acquired-by-labgenomics-to-expand-esoteric-testing-capabilities-globally2024-12-31https://www.crosstreecapital.com/deals/ils-genomics-acquired-by-labcorp-july-31-20152024-12-31https://www.crosstreecapital.com/insights/events/cns-summit2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-january-20232024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-20222024-02-14https://www.crosstreecapital.com/deals/dmed-acquired-clinipace2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-october-20232024-02-14https://www.crosstreecapital.com/deals/research-point-global-acquired-by-wuxi-apptec-october-17-20172024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-20202024-02-14https://www.crosstreecapital.com/deals/digital-healthcare-raised-3000000-preferred-stock-through-a-placement-agent2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-november-20222024-02-14https://www.crosstreecapital.com/contacthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract.jpgcrosstreebgabstractcrosstreebgabstracthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdark2026-02-24https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-may-20242024-06-17https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharma-technology-bluebook-march-20252025-04-22https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-january-20222024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-january-20242024-02-14https://www.crosstreecapital.com/deals/medisync-acquired-by-vyteris-april-18-20112024-12-31https://www.crosstreecapital.com/deals/hcs-acquired-by-girling2024-12-31https://www.crosstreecapital.com/deals/xenometrics-acquired-by-citoxlab-october-31-20172024-12-31https://www.crosstreecapital.com/deals/navinet-amount-raised-undisclosed-senior-debt-by-a-placement-agent2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-july-20212024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-20242024-11-04https://www.crosstreecapital.com/deals/pinnacle-clinical-research-a-portfolio-company-of-longuevue-capital-acquired-the-cognitive-and-research-center-of-new-jersey-to-expand-clinical-trial-site-network-to-expand-its-cns-trial-execution-capabilities2024-12-31https://www.crosstreecapital.com/deals/deep-6-ai-acquired-by-tempus2025-03-13https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-january-20242024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-september-20242024-11-04https://www.crosstreecapital.com/deals/mo-bio-acquired-by-qiagen-january-11-20162024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-june-20212024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-pharma-technology-bluebook-january-20252025-03-03https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-july-20242024-09-05https://www.crosstreecapital.com/deals/h-i-g-capital-acquires-majority-stake-in-navitas-life-sciences-to-accelerate-cro-growth2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-november-20212024-02-14https://www.crosstreecapital.com/insights/events/sot2024-12-31https://www.crosstreecapital.com/deals/converge-acquired-by-quest-diagnostics-october-7-20132024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-november-20242025-01-06https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-september-20222024-02-14https://www.crosstreecapital.com/testimonialshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Sandy-Ferber-Headshot-for-website-1.pngSandyFerberHeadshotforwebsite1SandyFerberHeadshotforwebsite1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/Trifecta-Logo.pngTrifectaLogoTrifectaLogohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/BioAgilytix-Logo-Hi-Res-e1616344833341-768x173.jpgBioAgilytixLogoHiRese1616344833341768x173BioAgilytixLogoHiRese1616344833341768x173https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/Enthalpy-p.jpgEnthalpypEnthalpyphttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/pharmasol_logo-rgb-768x204.pngpharmasollogorgb768x204pharmasollogorgb768x204https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Todd-Grosshandler-for-website.pngToddGrosshandlerforwebsiteToddGrosshandlerforwebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/Ascent-logo.pngAscentlogoAscentlogohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Stanton%20Kawer%20-%20Continuum%20Clinical.pngStantonKawerContinuumClinicalStantonKawerContinuumClinicalhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Doug-Engfer-for-website.pngDougEngferforwebsiteDougEngferforwebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Tim-Billington-Pharmasol.pngTimBillingtonPharmasolTimBillingtonPharmasolhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/integreviewlogo.pngintegreviewlogointegreviewlogohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/array-768x134.jpgarray768x134array768x134https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/download-1-e1633377000585.pngdownload1e1633377000585download1e1633377000585https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Client%20Testimonials.jpegClientTestimonialsClientTestimonialshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Soumitra-Chowdhury-website.pngSoumitraChowdhurywebsiteSoumitraChowdhurywebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/John-Winebarger_photo-circle.pngJohnWinebargerphotocircleJohnWinebargerphotocirclehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Logos/invivodata.pnginvivodatainvivodatahttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Testimonials/Headshots/Jim-Petrilla-for-website.pngJimPetrillaforwebsiteJimPetrillaforwebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/CC-Logo-2019-Horizontal-blue.pngCCLogo2019HorizontalblueCCLogo2019Horizontalblue2024-12-31https://www.crosstreecapital.com/deals/continuum-clinical-a-bc-worldwide-company-acquired-by-spectrum-science-a-portfolio-company-of-knox-lane-to-bolster-patient-engagement-capabilities2024-12-31https://www.crosstreecapital.com/insights/events/thanks/global-site-solutions-summit2024-08-28https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-april-20232024-02-14https://www.crosstreecapital.com/newsroomhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_email.svgiconemailiconemailhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_98249666-scaled-1.jpegAdobeStock98249666scaled1AdobeStock98249666scaled1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/AdobeStock_238800457.jpegAdobeStock238800457AdobeStock238800457https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(81)-1.pngUntitleddesign811Untitleddesign811https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdark2024-01-09https://www.crosstreecapital.com/deals/aj-home-care-inc-acquired-by-hcs2024-12-31https://www.crosstreecapital.com/videos/how-innovations-across-pharma-development-delivered-the-covid-19-vaccine-with-rick-ciminohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Gens-still-2.pngSteveGensstill2SteveGensstill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Cimino-Still-2.pngRickCiminoStill2RickCiminoStill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Riegel-Still-2.pngRickRiegelStill2RickRiegelStill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Sullivan-still-2.pngSteveSullivanstill2SteveSullivanstill22024-01-09https://www.crosstreecapital.com/insights/events/thanks/aaps2024-10-01https://www.crosstreecapital.com/about/team/gregorybare2025-04-15https://www.crosstreecapital.com/insights/events/thanks/world-vaccine-congress-europe2024-09-23https://www.crosstreecapital.com/privacy-policyhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract.jpgcrosstreebgabstractcrosstreebgabstract2024-02-14https://www.crosstreecapital.com/deals/aptilon-acquired-by-indegene-november-9-20122024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-november-20192024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-november-20202024-02-14https://www.crosstreecapital.com/insights/events/hlth2024-12-31https://www.crosstreecapital.com/deals/calyx-has-divested-its-enterprise-technology-division-to-ennov-to-enhance-ennovs-portfolio-of-eclinical-and-eregulatory-software-solutions2024-12-31https://www.crosstreecapital.com/focus/pharma-serviceshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024-ModularDevices-Flow.png2024ModularDevicesFlow2024ModularDevicesFlowhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Benchmark%20Research%20-%20IQVIA.png2024BenchmarkResearchIQVIA2024BenchmarkResearchIQVIAhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Pharma%20Services.jpegPharmaServicesPharmaServiceshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_box.svgiconboxiconboxhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Versiti%20-%20Pearl%20Pathways.png2024VersitiPearlPathways2024VersitiPearlPathwayshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCKerwin%20-%20Social.pngDealInsightCampaignLVCKerwinSocialDealInsightCampaignLVCKerwinSocialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(75).pngUntitleddesign75Untitleddesign75https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Vax%20Trials%20-%20Emmes.png2024VaxTrialsEmmes2024VaxTrialsEmmeshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCCRCNJ%20-%20Social.pngDealInsightCampaignLVCCRCNJSocialDealInsightCampaignLVCCRCNJSocialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Accel%20-%20Alcanza%20-%20Martis%20Capital.png2024AccelAlcanzaMartisCapital2024AccelAlcanzaMartisCapitalhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20SSI%20Strategy%20-%20Amulet%20Capital%20-%20NDA.png2024SSIStrategyAmuletCapitalNDA2024SSIStrategyAmuletCapitalNDAhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Grant%20Avenue%20-%20Creo.png2024GrantAvenueCreo2024GrantAvenueCreohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Calyx%20(Social%20Sized).V3-1.pngDealInsightCampaignTombstoneCalyxSocialSizedV31DealInsightCampaignTombstoneCalyxSocialSizedV31https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/AdobeStock_641600188.jpegAdobeStock641600188AdobeStock641600188https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deep%206%20AITempus%20(315%20x%20315%20px).pngDeep6AITempus315x315pxDeep6AITempus315x315pxhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Catalyst%20-%20QHP%20-%20Genpro.png2024CatalystQHPGenpro2024CatalystQHPGenprohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2%20(1).pngDealInsightCampaignMyonexCreapharmSocialV21DealInsightCampaignMyonexCreapharmSocialV21https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2.pngDealInsightCampaignMyonexCreapharmSocialV2DealInsightCampaignMyonexCreapharmSocialV2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Pharma%20Services%20-%20BlueBook.jpegPharmaServicesBlueBookPharmaServicesBlueBookhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sized.pngDealInsightCampaignTombstoneAlphaIRBSabaiGlobalSocialSizedDealInsightCampaignTombstoneAlphaIRBSabaiGlobalSocialSizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Continuum%20Clinical%20(Social%20Sized).pngDealInsightCampaignTombstoneContinuumClinicalSocialSizedDealInsightCampaignTombstoneContinuumClinicalSocialSizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Anju%20%2B%20Valsoft.pngDealInsightTombstoneAnjuValsoftDealInsightTombstoneAnjuValsofthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Campaign%20Tombstone%20-%20PhysIQ%20(Social%20Sized)%20(1).pngDealCampaignTombstonePhysIQSocialSized1DealCampaignTombstonePhysIQSocialSized1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20mbr%20-%20New%20harbor.png2024mbrNewharbor2024mbrNewharborhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Yecuris%20(Social%20Sized)%20(NEW).pngDealInsightCampaignTombstoneYecurisSocialSizedNEWDealInsightCampaignTombstoneYecurisSocialSizedNEWhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_money.svgiconmoneyiconmoneyhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_medical-case.svgiconmedicalcaseiconmedicalcase2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-february-20242024-03-14https://www.crosstreecapital.com/deals/mediatech-acquired-by-corning-december-1-20112024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-20242024-03-22https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-20212024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-december-20202024-02-14https://www.crosstreecapital.com/deals/dmd-acquired-by-aptilon-september-18-20092024-12-31https://www.crosstreecapital.com/insights/events/snmmi2025-01-08https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-march-20202024-02-14https://www.crosstreecapital.com/careers/openpositionshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract.jpgcrosstreebgabstractcrosstreebgabstract2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-bluebook-november-20242025-01-10https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-supply-chain-bluebook-january-20252025-02-26https://www.crosstreecapital.com/deals/endpoint-received-a-strategic-investment-from-chiltern-march-31-20102024-12-31https://www.crosstreecapital.com/bluebooks2024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-may-20232024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-august-20192024-02-14https://www.crosstreecapital.com/insights/events/lp/cns-summit2024-11-01https://www.crosstreecapital.com/insights/events/slas2024-12-31https://www.crosstreecapital.com/insights/events/acmg2025-02-11https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-february-20222024-02-14https://www.crosstreecapital.com/deals/gsk-is-selling-assets-to-foundation-consumer-healthcare2024-12-31https://www.crosstreecapital.com/insights/events/cphi-americas2025-03-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-january-20192024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-october-20232024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-february-20212024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-october-192024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-may-20192024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-20232024-02-14https://www.crosstreecapital.com/insights/events/himss2025-01-08https://www.crosstreecapital.com/insights/events/aacr2025-02-10https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-august-20232024-02-14https://www.crosstreecapital.com/insights/events/lp/sitc2024-11-01https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-march-20222024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-february-20252025-03-26https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-july-20212024-02-14https://www.crosstreecapital.com/deals/openclinica-completes-growth-recapitalization-with-thompson-street-capital-partners-to-accelerate-enablement-of-clinical-trials2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-january-20232024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-july-20212024-02-14https://www.crosstreecapital.com/deals/zebrasci-acquired-by-bd-to-enhance-combination-product-testing-capabilities2024-12-31https://www.crosstreecapital.com/deals/tulip-group-acquired-by-perkinelmer-january-9-20172024-12-31https://www.crosstreecapital.com/insights/events/thanks/chime-innovation-summit-southeast2025-03-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-march-20222024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-december-20222024-02-14https://www.crosstreecapital.com/deals/molecularmd-has-been-acquired-by-icon-plc2024-12-31https://www.crosstreecapital.com/insights/events/lp/dpharm2024-08-28https://www.crosstreecapital.com/deals/pathnet-acquired-by-labcorp-september-28-20082024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-december-2019-22024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-january-20202024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-december-20222024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-august-20242024-10-15https://www.crosstreecapital.com/insights/events/thanks2024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-20232024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-march-20202024-02-14https://www.crosstreecapital.com/deals/modular-devices-partners-with-flow-clean-room-and-supply2024-12-31https://www.crosstreecapital.com/deals/medifacts-international-acquired-by-global-research-services-march-23-20072024-12-31https://www.crosstreecapital.com/deals/omniseq-received-a-strategic-investment-from-hitachi-april-12-20182024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-march-20232024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-bluebook-december-20242025-01-21https://www.crosstreecapital.com/insights/events/ashg-annual-meeting2024-12-31https://www.crosstreecapital.com/insights/events/thanks/slas2024-11-15https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-may-20242024-06-17https://www.crosstreecapital.com/insights/events/lp/dcat-week2025-02-11https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-bluebook-february-20252025-03-26https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-march-20192024-02-14https://www.crosstreecapital.com/insights/events/lp/wrib2025-03-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-april-20232024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-sept-2019-22024-02-14https://www.crosstreecapital.com/deals/prophase-acquired-by-wcg-and-arsenal-capital-partners-may-9-20172024-12-31https://www.crosstreecapital.com/deals/worldcare-clinical-acquired-by-proscan-imaging-june-6-20062024-12-31https://www.crosstreecapital.com/deals/yecuris-acquired-by-janvier-group2024-12-31https://www.crosstreecapital.com/insights/events/lp/cphi-worldwide2024-08-29https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-november-20222024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-january-20252025-02-26https://www.crosstreecapital.com/deals/phoenix-data-systems-acquired-by-bioclinica-formerly-bio-imaging-technologies-april-28-20082024-12-31https://www.crosstreecapital.com/deals/phenopath-has-been-acquired-by-quest-diagnostics-september-20182024-12-31https://www.crosstreecapital.com/deals/clintrak-acquired-by-fisher-scientific-international-inc-april-11-20062024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-february-20212024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-september-20222024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-august-20212024-02-14https://www.crosstreecapital.com/deals/atherotech-financial-advisory2024-12-31https://www.crosstreecapital.com/white-paper/thank-you/precision-and-specialty-medicines-impact-on-the-future-of-clinical-trials2024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-20242025-01-06https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-january-20202024-02-14https://www.crosstreecapital.com/deals/versiti-acquired-quantigen-to-further-expand-clinical-trial-expertise-and-service-offering2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-february-20222024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-drug-development-bluebook-february-20252025-04-01https://www.crosstreecapital.com/deals/biorasi-received-a-majority-investment-from-riordan-lewis-haden-equity-partners-november-16-20182024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-december-20212024-02-14https://www.crosstreecapital.com/deals/pharmasol-acquired-by-pharmalex-to-offer-turnkey-end-to-end-pharmacovigilance-solutions2024-12-31https://www.crosstreecapital.com/about/teamhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Dominic-Stockey-Website.jpgDominicStockeyWebsiteDominicStockeyWebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Dan%20Niswonger_tie_color.jpgDanNiswongertiecolorDanNiswongertiecolorhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Stacey%20Troxell_Headshot%20-%20for%20website.jpgStaceyTroxellHeadshotforwebsiteStaceyTroxellHeadshotforwebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Shane-Senior-Website-2.jpgShaneSeniorWebsite2ShaneSeniorWebsite2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Jason-Layton-Website.jpgJasonLaytonWebsiteJasonLaytonWebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract.jpgcrosstreebgabstractcrosstreebgabstracthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Anne-Juarez-website.jpgAnneJuarezwebsiteAnneJuarezwebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Sara%20Casamiento%20website.pngSaraCasamientowebsiteSaraCasamientowebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Jeff-Ellis-Website.jpgJeffEllisWebsiteJeffEllisWebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Gregory%20Bare_tie_color.jpgGregoryBaretiecolorGregoryBaretiecolorhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Ben%20Garber_Color.jpgBenGarberColorBenGarberColorhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Cason-Searan_tie_Color-website.jpgCasonSearantieColorwebsiteCasonSearantieColorwebsitehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Mike%20Levin_tie_color.jpgMikeLevintiecolorMikeLevintiecolorhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Team/Gordon-Ryerson-Website-1.jpgGordonRyersonWebsite1GordonRyersonWebsite12025-04-15https://www.crosstreecapital.com/deals/medavante-acquired-by-arsenal-capital-partners-and-wcg-march-9-20172024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-july-20232024-02-14https://www.crosstreecapital.com/deals/citoxlab-acquired-solvo-biotechnology-march-12-20182024-12-31https://www.crosstreecapital.com/deals/biosafe-raised-6500000-subordinated-debt-through-a-placement-agent2024-12-31https://www.crosstreecapital.com/deals/ducere-pharma-acquired-by-dr-reddys-may-25-20162024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-20222024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-development-bluebook-february-20252025-04-01https://www.crosstreecapital.com/deals/haematologic-technologies-inc-was-acquired-by-edgewater-capital-partners2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-bluebook-december-20242025-01-21https://www.crosstreecapital.com/deals/medlabs-diagnostics-recapitalized-by-caymus-equity-and-pnc-mezzanine-capital-april-3-20182024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-january-20242024-02-20https://www.crosstreecapital.com/insights/events/lp/beckers-healthcare-health-it-digital-health-rcm-conference2024-08-28https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-october-20222024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-20202024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-june-20232024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-march-20252025-04-16https://www.crosstreecapital.com/insights/events/thanks/pegs-europe2024-10-01https://www.crosstreecapital.com/deals/pacific-physicians-laboratory-inc-acquired-by-labcorp-december-11-20122024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-october-192024-02-14https://www.crosstreecapital.com/white-paper/thank-you/positioning-biobanking-assets-for-maximum-value2024-02-14https://www.crosstreecapital.com/insights/eventshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-23T144347.826.pngUntitleddesign20240923T144347826Untitleddesign20240923T144347826https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-23T145900.585.pngUntitleddesign20240923T145900585Untitleddesign20240923T145900585https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-08-29T125134.154.pngUntitleddesign20240829T125134154Untitleddesign20240829T125134154https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-23T142903.167.pngUntitleddesign20240923T142903167Untitleddesign20240923T142903167https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-09-23T143707.101.pngUntitleddesign20240923T143707101Untitleddesign20240923T143707101https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-01T142250.750.pngUntitleddesign20241101T142250750Untitleddesign20241101T142250750https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-10-01T121313.042.pngUntitleddesign20241001T121313042Untitleddesign20241001T121313042https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-12T162536.396.pngUntitleddesign20241112T162536396Untitleddesign20241112T162536396https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-19T111642.502.pngUntitleddesign20250319T111642502Untitleddesign20250319T111642502https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-08T143859.490.pngUntitleddesign20250408T143859490Untitleddesign20250408T143859490https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-08-29T130644.160.pngUntitleddesign20240829T130644160Untitleddesign20240829T130644160https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-08-29T124544.883.pngUntitleddesign20240829T124544883Untitleddesign20240829T124544883https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-01T103926.358.pngUntitleddesign20241101T103926358Untitleddesign20241101T103926358https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-01-08T112429.317.pngUntitleddesign20250108T112429317Untitleddesign20250108T112429317https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-01T144217.760.pngUntitleddesign20241101T144217760Untitleddesign20241101T144217760https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-08-29T130232.151.pngUntitleddesign20240829T130232151Untitleddesign20240829T130232151https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-19T115408.077.pngUntitleddesign20250319T115408077Untitleddesign20250319T115408077https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-18T145326.777.pngUntitleddesign20241118T145326777Untitleddesign20241118T145326777https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-08-29T125609.141.pngUntitleddesign20240829T125609141Untitleddesign20240829T125609141https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-11T164817.019.pngUntitleddesign20250211T164817019Untitleddesign20250211T164817019https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-11T170828.896.pngUntitleddesign20250211T170828896Untitleddesign20250211T170828896https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202024-11-15T121810.962.pngUntitleddesign20241115T121810962Untitleddesign20241115T121810962https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-02-11T170500.135.pngUntitleddesign20250211T170500135Untitleddesign20250211T1705001352024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-july-20242024-09-05https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-december-20212024-02-14https://www.crosstreecapital.com/deals/monroe-biomedical-research-acquired-by-new-harbor-capital-in-a-first-step-to-build-out-a-clinical-research-site-platform2024-12-31https://www.crosstreecapital.com/deals/imp-logistics-acquired-by-pra-and-genstar-capital-llc-march-4-20132024-12-31https://www.crosstreecapital.com/deals/pacific-data-designs-acquired-by-dw-healthcare-partners-november-6-20082024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-sept-2019-22024-02-14https://www.crosstreecapital.comhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Tombstone_ROI_01_28_2026-1.pngTombstoneROI012820261TombstoneROI012820261https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2%20(1).pngDealInsightCampaignMyonexCreapharmSocialV21DealInsightCampaignMyonexCreapharmSocialV21https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20BBIIBEX.pngDealInsightCampaignTombstoneBBIIBEXDealInsightCampaignTombstoneBBIIBEXhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20sengenics%20(2).pngDealInsightTombstonesengenics2DealInsightTombstonesengenics2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-14T103931.881.pngUntitleddesign20250414T103931881Untitleddesign20250414T103931881https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Hompage%20V3.jpgHompageV3HompageV3https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-03-17T150049.946.pngUntitleddesign20250317T150049946Untitleddesign20250317T150049946https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/ROI%20Healthcare%20Deal%20Featured%20Image%20(1).pngROIHealthcareDealFeaturedImage1ROIHealthcareDealFeaturedImage1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_health-phone.svgiconhealthphoneiconhealthphonehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Versiti%20-%20Pearl%20Pathways.png2024VersitiPearlPathways2024VersitiPearlPathwayshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Continuum%20Clinical%20(Social%20Sized).pngDealInsightCampaignTombstoneContinuumClinicalSocialSizedDealInsightCampaignTombstoneContinuumClinicalSocialSizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Vax%20Trials%20-%20Emmes.png2024VaxTrialsEmmes2024VaxTrialsEmmeshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Value%20Creation%20Servicesv2.jpgValueCreationServicesv2ValueCreationServicesv2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sized.pngDealInsightCampaignTombstoneAlphaIRBSabaiGlobalSocialSizedDealInsightCampaignTombstoneAlphaIRBSabaiGlobalSocialSizedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCKerwin%20-%20Social.pngDealInsightCampaignLVCKerwinSocialDealInsightCampaignLVCKerwinSocialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Yecuris%20(Social%20Sized)%20(NEW).pngDealInsightCampaignTombstoneYecurisSocialSizedNEWDealInsightCampaignTombstoneYecurisSocialSizedNEWhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20LVCCRCNJ%20-%20Social.pngDealInsightCampaignLVCCRCNJSocialDealInsightCampaignLVCCRCNJSocialhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Recapitaliztion.jpegRecapitaliztionRecapitaliztionhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-16T103632.637.pngUntitleddesign20250416T103632637Untitleddesign20250416T103632637https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Anju%20%2B%20Valsoft.pngDealInsightTombstoneAnjuValsoftDealInsightTombstoneAnjuValsofthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-22T150033.284.pngUntitleddesign20250422T150033284Untitleddesign20250422T150033284https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20iPeople%20(3).pngDealInsightTombstoneiPeople3DealInsightTombstoneiPeople3https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_microscope-list.svgiconmicroscopelisticonmicroscopelisthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Calyx%20(Social%20Sized).V3-1.pngDealInsightCampaignTombstoneCalyxSocialSizedV31DealInsightCampaignTombstoneCalyxSocialSizedV31https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deep%206%20AITempus%20(315%20x%20315%20px).pngDeep6AITempus315x315pxDeep6AITempus315x315pxhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20Biotechne.pngDealInsightTombstoneBiotechneDealInsightTombstoneBiotechnehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2.pngDealInsightCampaignMyonexCreapharmSocialV2DealInsightCampaignMyonexCreapharmSocialV2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20-%202025-04-16T110543.792.pngUntitleddesign20250416T110543792Untitleddesign20250416T110543792https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Campaign%20Tombstone%20-%20PhysIQ%20(Social%20Sized)%20(1).pngDealCampaignTombstonePhysIQSocialSized1DealCampaignTombstonePhysIQSocialSized1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/M&A%20Advisory.jpgMAAdvisoryMAAdvisoryhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_test-tube.svgicontesttubeicontesttubehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20ActiGraph%20(1).pngDealInsightTombstoneActiGraph1DealInsightTombstoneActiGraph1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024-ModularDevices-Flow.png2024ModularDevicesFlow2024ModularDevicesFlow2025-03-11https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-20222024-02-14https://www.crosstreecapital.com/deals/caremetx-owned-by-the-vistria-group-acquired-virmedica-owned-by-petra-capital-partners-september-20182024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-bluebook-may-20192024-02-14https://www.crosstreecapital.com/focus/healthcare-technologyhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20DataCeutics%20%2B%20Navitas.png2024DataCeuticsNavitas2024DataCeuticsNavitashttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20iPeople%20(3).pngDealInsightTombstoneiPeople3DealInsightTombstoneiPeople3https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(78).pngUntitleddesign78Untitleddesign78https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20WCG%20-%20LGP.png2024WCGLGP2024WCGLGPhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20PMI%20-%20Covance.png2024PMICovance2024PMICovancehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Campaign%20Tombstone%20-%20PhysIQ%20(Social%20Sized)%20(1).pngDealCampaignTombstonePhysIQSocialSized1DealCampaignTombstonePhysIQSocialSized1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_medical-case.svgiconmedicalcaseiconmedicalcasehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20OmniComm%20-%20anju.png2024OmniCommanju2024OmniCommanjuhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Expertise-Healthcare%20Technology.jpgExpertiseHealthcareTechnologyExpertiseHealthcareTechnologyhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Clinical%20Site%20Services%20-%20ACRS%20-%20Latticework.png2024ClinicalSiteServicesACRSLatticework2024ClinicalSiteServicesACRSLatticeworkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Pharmica%20-%20Propharma%20Group.png2024PharmicaPropharmaGroup2024PharmicaPropharmaGrouphttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Trifecta%20-%20WCG.png2024TrifectaWCG2024TrifectaWCGhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Protocol%20First%20-%20Flatiron%20-%20Roche.png2024ProtocolFirstFlatironRoche2024ProtocolFirstFlatironRochehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20ActiGraph%20(1).pngDealInsightTombstoneActiGraph1DealInsightTombstoneActiGraph1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Campaign%20Tombstone%20-%20Calyx%20(Social%20Sized).V3-1.pngDealInsightCampaignTombstoneCalyxSocialSizedV31DealInsightCampaignTombstoneCalyxSocialSizedV31https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/icons/icon_gear.svgicongearicongearhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Pharmasol%20-%20Pharmalex.png2024PharmasolPharmalex2024PharmasolPharmalexhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Intrinsic%20-%20Propharma%20Group.png2024IntrinsicPropharmaGroup2024IntrinsicPropharmaGrouphttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(77).pngUntitleddesign77Untitleddesign77https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Virmedica%20-%20CareMetx.png2024VirmedicaCareMetx2024VirmedicaCareMetxhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/BlueBook%20-%20Health%20Tech.jpgBlueBookHealthTechBlueBookHealthTechhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20UpStream%20-%20Dragoneer.png2024UpStreamDragoneer2024UpStreamDragoneerhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Tombstone_ROI_01_28_2026-1.pngTombstoneROI012820261TombstoneROI012820261https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/AdobeStock_559486634.jpegAdobeStock559486634AdobeStock559486634https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Catalyst%20-%20QHP%20-%20Genpro.png2024CatalystQHPGenpro2024CatalystQHPGenprohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Velos%20-%20WCG.png2024VelosWCG2024VelosWCGhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Deal%20Insight%20Tombstone%20sengenics%20(2).pngDealInsightTombstonesengenics2DealInsightTombstonesengenics22024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-20242024-11-04https://www.crosstreecapital.com/white-paper/precision-and-specialty-medicines-impact-on-the-future-of-clinical-trials2024-07-29https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-october-20242024-11-26https://www.crosstreecapital.com/deals/synthetech-acquired-by-grace-september-13-20102024-12-31https://www.crosstreecapital.com/deals/paragon-biomedical-acquired-by-clinipace-worldwide-september-25-20122024-12-31https://www.crosstreecapital.com/deals/roi-healthcare-solutions-acquired-by-acuvance-a-portfolio-company-of-trinity-hunt2026-02-02https://www.crosstreecapital.com/insights/events/thanks/vive2025-01-08https://www.crosstreecapital.com/deals/pharmaceutical-profiles-acquired-by-quotient-bioscience-december-15-20082024-12-31https://www.crosstreecapital.com/insights/events/aaps-national-biotechnology-conference2025-03-19https://www.crosstreecapital.com/insights/events/lp/world-vaccine-congress2025-04-08https://www.crosstreecapital.com/insights/events/thanks/acmg2025-02-11https://www.crosstreecapital.com/insights/events/thanks/scope-summit2024-11-01https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-20232024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-november-20212024-02-14https://www.crosstreecapital.com/deals/trevigen-acquired-by-bio-techne-september-5-20172024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-20232024-02-14https://www.crosstreecapital.com/deals/sengenics-a-portfolio-company-of-summa-equity-acquired-by-standard-biotools2025-01-28https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-march-20242024-04-12https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-november-20232024-02-14https://www.crosstreecapital.com/deals/quartesian-acquired-by-summit-partners-to-form-new-global-outsourced-medtech-provider2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-bluebook-january-20192024-02-14https://www.crosstreecapital.com/deals/catalyst-clinical-research-a-portfolio-company-of-qhp-capital-acquired-genpro-research-to-expand-global-footprint-and-deepen-service-offerings2024-12-31https://www.crosstreecapital.com/insights/events/global-site-solutions-summit2024-12-31https://www.crosstreecapital.com/deals/curetis-and-opgen-enter-into-definitive-agreement-to-combine-businesses2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-march-20232024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-april-20192024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-september-20232024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-february-20232024-02-14https://www.crosstreecapital.com/deals/flourish-research-acquires-excel-medical-clinical-trials-to-expand-site-network-and-therapeutic-expertise2024-12-31https://www.crosstreecapital.com/insights/events/vive2025-01-08https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-february-20232024-02-14https://www.crosstreecapital.com/newsroom/crosstree-redefines-brand-image-and-unveils-enhanced-strategic-consulting-serviceshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/insights/AdobeStock_98249666-scaled-1.jpegAdobeStock98249666scaled1AdobeStock98249666scaled1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Untitled%20design%20(81)-1.pngUntitleddesign811Untitleddesign8112024-03-21https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharma-technology-bluebook-february-20252025-03-31https://www.crosstreecapital.com/insights/events/thanks/bio-it-world-venture2025-02-11https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-20212024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharma-technology-bluebook-january-20252025-03-03https://www.crosstreecapital.com/about/team/dominic-stockey2025-04-15https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-january-20212024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-july-20232024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-20212024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-july-20232024-02-14https://www.crosstreecapital.com/bluebooks/thank-you2024-02-14https://www.crosstreecapital.com/insights/events/lp/pharma-ci-conference2024-09-23https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-november-20242025-01-06https://www.crosstreecapital.com/business-continuityhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract.jpgcrosstreebgabstractcrosstreebgabstracthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdark2024-02-14https://www.crosstreecapital.com/white-paper/inorganic-growth-strategies-in-precision-medicine2024-07-29https://www.crosstreecapital.com/article/precisionmedicinedrivinghttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Arrows_Orange2.jpgArrowsOrange2ArrowsOrange2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/NewArticle-2.pngNewArticle2NewArticle2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Feb-2021-Content.pngFeb2021ContentFeb2021Content2024-01-04https://www.crosstreecapital.com/deals/bridge-laboratories-raised-35m-in-series-b-preferred-shares-from-aisling-capital-and-lehman-brothers-june-14-20062024-12-31https://www.crosstreecapital.com/insights/events/lp/dia-eu2025-02-11https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-january-20192024-02-14https://www.crosstreecapital.com/deals/upstream-completes-45-million-funding-round-led-by-dragoneer-to-revolutionize-care-for-older-adults2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-december-20202024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-april-20212024-02-14https://www.crosstreecapital.com/deals/datalabs-acquired-by-clinphone-october-27-20062024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-bluebook-january-20252025-02-28https://www.crosstreecapital.com/deals/focus-pharmaceuticals-ltd-acquired-by-amco-october-1-20142024-12-31https://www.crosstreecapital.com/insights/events/thanks/cphi-americas2025-03-19https://www.crosstreecapital.com/market-map2024-01-09https://www.crosstreecapital.com/insights/events/lp/pegs-europe2024-10-01https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-december-20242025-01-21https://www.crosstreecapital.com/insights/events/world-drug-safety-congress-americas-20242024-12-31https://www.crosstreecapital.com/deals/gq-life-sciences-acquired-by-aptean-october-3-20162024-12-31https://www.crosstreecapital.com/deals/american-diagnostica-acquired-by-sckisui-march-23-20092024-12-31https://www.crosstreecapital.com/about/team/cason-searan2025-04-15https://www.crosstreecapital.com/deals/micronics-raised-6m-in-series-b-preferred-shares-october-16-20082024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-pharmaceutical-commerce-bluebook-march-20252025-04-16https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-june-20232024-02-14https://www.crosstreecapital.com/deals/genstar-capital-acquires-advarra-from-linden-partners2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-april-20212024-02-14https://www.crosstreecapital.com/deals/pht-acquired-by-ert-and-genstar-capital-may-11-20152024-12-31https://www.crosstreecapital.com/insights/events/thanks/jpm2024-11-01https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-february-20242024-03-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-november-20202024-02-14https://www.crosstreecapital.com/deals/transposagen-biopharmaceuticals-inc-has-been-acquired-by-lonza2024-12-31https://www.crosstreecapital.com/videos/global-connectivity-and-pharma-development-innovation-with-steve-genshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Gens-still-2.pngSteveGensstill2SteveGensstill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Riegel-Still-2.pngRickRiegelStill2RickRiegelStill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Cimino-Still-2.pngRickCiminoStill2RickCiminoStill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Sullivan-still-2.pngSteveSullivanstill2SteveSullivanstill22024-01-09https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-september-20232024-02-14https://www.crosstreecapital.com/deals/omniseq-received-a-strategic-investment-from-labcorp-august-21-20172024-12-31https://www.crosstreecapital.com/deals/perrigo-advances-consumer-strategy-with-acquisition-of-prevacid24hr-from-gsk2024-12-31https://www.crosstreecapital.com/deals/cliniqa-acquired-by-bio-techne-july-9-20152024-12-31https://www.crosstreecapital.com/what-we-do/strategy-advisory-and-origination-serviceshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Versiti%20-%20Pearl%20Pathways.png2024VersitiPearlPathways2024VersitiPearlPathwayshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Value%20Creation%20-%20Strategy.jpgValueCreationStrategyValueCreationStrategyhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20LVC%20-%20Summit%20Clinical%20Research.png2024LVCSummitClinicalResearch2024LVCSummitClinicalResearchhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Grant%20Avenue%20-%20Creo.png2024GrantAvenueCreo2024GrantAvenueCreohttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Clairvest%20-%20BocaBiolistics.png2024ClairvestBocaBiolistics2024ClairvestBocaBiolisticshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20SSI%20Strategy%20-%20Amulet%20Capital%20-%20NDA.png2024SSIStrategyAmuletCapitalNDA2024SSIStrategyAmuletCapitalNDAhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Value%20Creation%20-%20Growth.jpgValueCreationGrowthValueCreationGrowthhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/AdobeStock_288913742.jpegAdobeStock288913742AdobeStock288913742https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Value%20Creation%20Services%20-%20Image%201.jpgValueCreationServicesImage1ValueCreationServicesImage1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Flourish%20-%20Excel%20Medical.png2024FlourishExcelMedical2024FlourishExcelMedicalhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Digital%20Healthcare%20-%20Placement%20Agent%20(2).png2024DigitalHealthcarePlacementAgent22024DigitalHealthcarePlacementAgent2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20ClinChoice%20-%20Crom%20Source.png2024ClinChoiceCromSource2024ClinChoiceCromSourcehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20HIG%20Capital%20-%20NAVITAS.png2024HIGCapitalNAVITAS2024HIGCapitalNAVITAShttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Versiti%20-%20Quantizen.png2024VersitiQuantizen2024VersitiQuantizenhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20DMed%20-%20Clinipace.png2024DMedClinipace2024DMedClinipacehttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024-ModularDevices-Flow.png2024ModularDevicesFlow2024ModularDevicesFlowhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Value%20Creation%20Servicesv2.jpgValueCreationServicesv2ValueCreationServicesv2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Pyxant%20Labs%20-%20ArchiMed.png2024PyxantLabsArchiMed2024PyxantLabsArchiMedhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/VCS%20-%20Add-on.jpgVCSAddonVCSAddonhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Catalyst%20-%20QHP%20-%20Genpro.png2024CatalystQHPGenpro2024CatalystQHPGenpro2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-april-20192024-02-14https://www.crosstreecapital.com/white-paper/thank-you2024-02-14https://www.crosstreecapital.com/article/crosstree-in-pharmavoice-feb-2021https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Feb-2021-Content.pngFeb2021ContentFeb2021Contenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/Arrows_Orange2.jpgArrowsOrange2ArrowsOrange2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Insights/Articles/NewArticle-2.pngNewArticle2NewArticle22024-01-09https://www.crosstreecapital.com/about/team/anne-juarez2025-04-15https://www.crosstreecapital.com/insights/events/aaps2024-12-31https://www.crosstreecapital.com/insights/events/thanks/dealmax2025-02-10https://www.crosstreecapital.com/what-we-do/recapitalizationhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Endpoint%20-%20Chiltern.png2024EndpointChiltern2024EndpointChilternhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20WCG%20-%20LGP.png2024WCGLGP2024WCGLGPhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20OmniSeq%20-%20LabCorp.png2024OmniSeqLabCorp2024OmniSeqLabCorphttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20NaviNet%20-%20Placement%20Agent.png2024NaviNetPlacementAgent2024NaviNetPlacementAgenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Romark%20Laboratories%20-%20Placement%20Agent%20(2)%20(1).png2024RomarkLaboratoriesPlacementAgent212024RomarkLaboratoriesPlacementAgent21https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20OmniSeq%20-%20Hitachi.png2024OmniSeqHitachi2024OmniSeqHitachihttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Micronics.png2024Micronics2024Micronicshttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Scandius%20-%20Placement%20Agent.png2024ScandiusPlacementAgent2024ScandiusPlacementAgenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Gentiae%20-%20Baby%20City%20Capital.png2024GentiaeBabyCityCapital2024GentiaeBabyCityCapitalhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Chemical%20Computing%20group%20-%20Altaris.png2024ChemicalComputinggroupAltaris2024ChemicalComputinggroupAltarishttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-Epharmasolutions%20-%20WCG.png2024EpharmasolutionsWCG2024EpharmasolutionsWCGhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Bridge%20-%20Aisling%20Capital.png2024BridgeAislingCapital2024BridgeAislingCapitalhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Biorasi%20-%20Riordan%2c%20Lewis%20&%20Haden.png2024BiorasiRiordanLewisHaden2024BiorasiRiordanLewisHadenhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Medsphere%20-%20Placement%20Agent.png2024MedspherePlacementAgent2024MedspherePlacementAgenthttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20UpStream%20-%20Dragoneer.png2024UpStreamDragoneer2024UpStreamDragoneerhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Romark%20Laboratories%20-%20Placement%20Agent%20(2).png2024RomarkLaboratoriesPlacementAgent22024RomarkLaboratoriesPlacementAgent2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Chronometriq%20-%20fi.png2024Chronometriqfi2024Chronometriqfihttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Realtime%20Clinical%20Trial%20-%20LLR%20Partners.png2024RealtimeClinicalTrialLLRPartners2024RealtimeClinicalTrialLLRPartnershttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Digital%20Healthcare%20-%20Placement%20Agent%20(2)%20(1).png2024DigitalHealthcarePlacementAgent212024DigitalHealthcarePlacementAgent21https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/What%20We%20Do%20-%20Recap1.jpgWhatWeDoRecap1WhatWeDoRecap1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/2024%20-%20Open%20Clinica%20-%20Thompson%20Street%20(1).png2024OpenClinicaThompsonStreet12024OpenClinicaThompsonStreet1https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/images/Recapitaliztion.jpegRecapitaliztionRecapitaliztion2024-12-31https://www.crosstreecapital.com/deals/myonex-acquired-creapharms-clinical-and-commercial-packaging-and-bioservices-business-units2024-12-31https://www.crosstreecapital.com/insights/events/lp/world-vaccine-congress-europe2024-09-23https://www.crosstreecapital.com/deals/chemical-computing-group-received-a-majority-investment-from-altaris-june-8-20172024-12-31https://www.crosstreecapital.com/about/team/shanesenior2025-04-15https://www.crosstreecapital.com/insights/events/thanks/sot2024-11-15https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-september-20202024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-december-2019-22024-02-14https://www.crosstreecapital.com/about/team/danielniswonger2025-04-15https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-september-20222024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-september-20202024-02-14https://www.crosstreecapital.com/deals/grenova-completes-growth-recapitalization-with-peloton-equity-to-accelerate-strategic-objectives2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-july-20192024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-drug-supply-chain-bluebook-february-20252025-03-26https://www.crosstreecapital.com/video2024-09-24https://www.crosstreecapital.com/insights/events/lp/ahima-24-conference2024-09-23https://www.crosstreecapital.com/deals/array-biostatistics-was-acquired-by-cato-sms2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-april-20242024-05-09https://www.crosstreecapital.com/deals/bridge-laboratories-acquired-the-preclinical-testing-division-of-gene-logic-december-20-20062024-12-31https://www.crosstreecapital.com/deals/biomain-acquired-by-heraeus-march-1-20122024-12-31https://www.crosstreecapital.com/deals/mdci-acquired-by-aptiv-solutions-and-sv-life-sciences-august-22-20112024-12-31https://www.crosstreecapital.com/insights/events/thanks/world-drug-safety-congress-americas-20242024-09-23https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-20242024-04-17https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-20212024-02-14https://www.crosstreecapital.com/about/team/jeffellis2025-04-15https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-march-20232024-02-14https://www.crosstreecapital.com/deals/ttm-acquired-by-indegene-january-2-20142024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-january-20202024-02-14https://www.crosstreecapital.com/about/team/sara-casamento2026-02-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-20222024-02-14https://www.crosstreecapital.com/deals/gsk-sold-assets-to-crown-laboratories2024-12-31https://www.crosstreecapital.com/insights/events/dealmax2025-02-10https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-october-20212024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-june-20192024-02-14https://www.crosstreecapital.com/deals/clairvest-acquires-boca-biolistics-to-accelerate-growth-of-infectious-disease-and-oncological-biobanking-capabilities2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-march-20242024-04-17https://www.crosstreecapital.com/deals/physiq-acuired-by-prolaio2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-may-20202024-02-14https://www.crosstreecapital.com/deals/grant-avenue-capital-recapitalizes-creo2024-12-31https://www.crosstreecapital.com/white-paper/thank-you/inorganic-growth-strategies-in-precision-medicine2024-02-14https://www.crosstreecapital.com/insights/events/pharma-ci-conference2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-20202024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-december-20202024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-february-20242024-03-22https://www.crosstreecapital.com/deals/chonometriq-received-an-investment-from-full-in-partners-october-1-20192024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-may-20232024-02-14https://www.crosstreecapital.com/deals/santus-laboratories-owned-by-healthedge-partners-sold-cough-cold-asset-to-reliable1-august-20182024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-march-20222024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-20222024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-august-20192024-02-14https://www.crosstreecapital.com/deals/rmc-pharmaceutical-solutions-acquired-by-syner-g-biopharma-group-a-portfolio-company-of-riverside-partners-to-expand-regulatory-compliance-solutions2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-february-20192024-02-14https://www.crosstreecapital.com/insights/events/lp/scope-summit2024-11-01https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-august-20192024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-february-20202024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-october-20242024-11-26https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-june-20242024-07-26https://www.crosstreecapital.com/deals/infopro-acquired-by-aptuit-november-14-20052024-12-31https://www.crosstreecapital.com/insights/events/thanks/snmmi2025-01-08https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-july-20202024-02-14https://www.crosstreecapital.com/insights/events/lp/hlth2024-08-29https://www.crosstreecapital.com/deals/anju-software-acquires-omnicomm-systems2024-12-31https://www.crosstreecapital.com/deals/integreview-was-acquired-by-advarra2024-12-31https://www.crosstreecapital.com/insights/events/thanks/beckers-annual-meeting2025-03-19https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-march-20232024-02-14https://www.crosstreecapital.com/insights/events/beckers-annual-meeting2025-03-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-september-20212024-02-14https://www.crosstreecapital.com/insights/events/lp/global-site-solutions-summit2024-08-28https://www.crosstreecapital.com/insights/events/chime-innovation-summit-southeast2025-03-19https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-december-20212024-02-14https://www.crosstreecapital.com/deals/velos-acquired-wcg-a-portfolio-company-of-arsenal-capital-partners2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-pharmaceutical-commerce-bluebook-march-20252025-04-16https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-20192024-02-14https://www.crosstreecapital.com/insights/events/lp/chime-innovation-summit-southeast2025-03-19https://www.crosstreecapital.com/deals/csm-a-portfolio-company-of-great-point-partners-has-been-acquired-by-clinigen-september-20182024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-20202024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-april-20242024-05-13https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-august-20232024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-may-20222024-02-14https://www.crosstreecapital.com/insights/events/pegs-europe2024-12-31https://www.crosstreecapital.com/deals/clinical-trials-of-texas-recapitalized-by-nms-capital-to-form-new-flourish-research-clinical-research-site-platform2024-12-31https://www.crosstreecapital.com/deals/senova-systems-acquired-by-parker2024-12-31https://www.crosstreecapital.com/deals/dataceutics-has-been-acquired-by-navitas-life-sciences-a-take-solutions-company2024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-january-20192024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-july-20192024-02-14https://www.crosstreecapital.com/insights/events/thanks/hlth2024-08-29https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-20192024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-april-20232024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-bluebook-april-20192024-02-14https://www.crosstreecapital.com/insights/events/dpharm2024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-april-20222024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-february-20232024-02-14https://www.crosstreecapital.com/deals/prostalund-acquired-by-farstorp2024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-november-20202024-02-14https://www.crosstreecapital.com/insights/events/beckers-healthcare-health-it-digital-health-rcm-conference2024-12-31https://www.crosstreecapital.com/insights/events/lp/beckers-annual-meeting2025-03-19https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-october-20202024-02-14https://www.crosstreecapital.com/deals/actigraph-a-portfolio-company-of-archimed-acquired-biofourmis-life-science-business2025-01-07https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-july-20202024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-october-20212024-02-14https://www.crosstreecapital.com/videos/covid-19-impact-on-pharma-development-innovation-with-steve-sullivanhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Riegel-Still-2.pngRickRiegelStill2RickRiegelStill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/theme-crosstree/backgrounds/crosstree_bg_abstract_dark.jpgcrosstreebgabstractdarkcrosstreebgabstractdarkhttps://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Sullivan-still-2.pngSteveSullivanstill2SteveSullivanstill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Steve-Gens-still-2.pngSteveGensstill2SteveGensstill2https://5254426.fs1.hubspotusercontent-na1.net/hubfs/5254426/Imported_Blog_Media/Rick-Cimino-Still-2.pngRickCiminoStill2RickCiminoStill22024-01-09https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-august-20202024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-may-20212024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-april-20242024-05-13https://www.crosstreecapital.com/white-paper/positioning-biobanking-assets-for-maximum-value2024-07-29https://www.crosstreecapital.com/deals/cytolab-pathology-services-acquired-by-labcorp-december-11-20122024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-blue-book-april-20222024-02-14https://www.crosstreecapital.com/deals/epharmasolutions-received-a-strategic-investment-from-arsenal-capital-partners-and-wirb-copernicus-group-september-24-20142024-12-31https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-december-20222024-02-14https://www.crosstreecapital.com/deals/dynarand-acquired-by-ubc-april-21-20052024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-may-20232024-02-14https://www.crosstreecapital.com/bluebooks/pharma-services-blue-book-june-20202024-02-14https://www.crosstreecapital.com/deals/healthcare-discoveries-acquired-by-icon-february-11-20082024-12-31https://www.crosstreecapital.com/about/team/bengarber2025-04-15https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-may-20192024-02-14https://www.crosstreecapital.com/white-paper/white-paperpatient-access-organizations-an-emerging-ecosystem2024-07-29https://www.crosstreecapital.com/deals/bct-recapitalized-by-martis-capital-via-its-newly-formed-clinical-research-site-platform-alcanza-clinical-research2024-12-31https://www.crosstreecapital.com/deals/enthalpy-bioanalytical-testing-division-acquired-by-labcorp-june-11-20102024-12-31https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-may-20192024-02-14https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-april-20202024-02-14https://www.crosstreecapital.com/about/team/mikelevin2025-04-15https://www.crosstreecapital.com/bluebooks/thank-you/pharma-services-drug-supply-chain-bluebook-february-20252025-03-26https://www.crosstreecapital.com/bluebooks/diagnostics-and-tools-blue-book-january-20242024-02-20https://www.crosstreecapital.com/insights/events/thanks/acg-florida-capital-connection2024-11-12https://www.crosstreecapital.com/bluebooks/diagnostics-tools-bluebook-february-20202024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-and-tools-blue-book-june-20222024-02-14https://www.crosstreecapital.com/bluebooks/thank-you/diagnostics-tools-bluebook-november-20192024-02-14https://www.crosstreecapital.com/deals/drugdev-acquired-by-quintilesims2024-12-31https://www.crosstreecapital.com/deals/bioagilytix-labs-acquired-by-riverside-partners-june-4-20132024-12-31https://www.crosstreecapital.com/bluebooks/pharma-services-bluebook-february-20192024-02-14https://www.crosstreecapital.com/deals/clinical-pharmacology-of-miami-acquired-by-evolution-research-group2024-12-31